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SUMMARY 
Sickle cell anemia (SCA) is a genetic blood disorder which affects over 4 million 
people globally.  Though SCA is caused by a single point mutation in the hemoglobin of 
red blood cells, this change has devastating affects which can impact the entire human body 
and reduce life expectancy. Amongst the complications associated with SCA, there is a 
200-fold increase in the likelihood of ischemic stroke in children and adolescents. 
Approximately 11.5% of individuals with SCA will develop an overt stroke before 18 years 
of age, and those between 2 and 5 at the greatest risk. Additionally, 37% of individuals will 
have a silent stroke before the age of 14. The only method to determine stroke risk is with 
through transcranial doppler and measuring blood flow in the cerebral arteries. Individuals 
who have a time-average maximum-mean blood velocity exceeding 200 cm/s have a 
significantly elevated risk of developing a stroke in the future. The objective of this thesis 
is to provide insight into these elevated blood velocities by identifying and validating flow-
mediated mechanisms predisposing children with sickle cell anemia to strokes. 
Individuals with SCA have shown remarkable cerebrovascular remodeling 
characterized by intimal hyperplasia and luminal narrowing, specifically in the distal 
internal carotid artery (ICA), middle cerebral artery (MCA), and anterior cerebral artery 
(ACA). Formation of stenoses in these arteries could produce elevated velocities; however, 
higher blood velocities have also been measured in individuals despite a lack of 
morphological abnormalities. Therefore, the relationship between geometry and 
hemodynamics is crucial to understanding the biomechanical mechanisms causing 
accelerated stroke development in SCA. 
 xxi 
Using computational fluid dynamics (CFD), we have demonstrated that individuals 
with SCA have elevated blood velocities, even when inlet boundary conditions were 
equivalent to those without SCA. This indicates geometrical differences are a plausible 
cause for the elevated velocities indicative of strokes risk. In addition to these findings, 
individuals with SCA had increased regions of low and oscillatory shear stress, a stimulus 
for endothelial dysfunction and vascular remodeling. The role of geometry was further 
investigated using the Townes sickle cell transgenic mouse model. Through a combination 
of live imaging with ultrasound and perfusion casting, morphometrics were measured in 
the carotid and cerebral arteries of homozygous sickle (SS) and heterozygous sickle (AS) 
mice. SS mice were found to have significantly larger common carotid artery diameters 
than AS mice, and significantly larger diameters in the extracranial and intracranial 
portions of the ICA. Significant narrowing was also determined along ICA, decreasing by 
as much as 70%, such that the terminal tributaries of the MCA and ACA had no differences 
in size between genotypes. CFD simulations with mouse geometries indicated that 
narrowing in the cerebral arteries of SS mice correlated with elevated cerebral blood 
velocities. Specifically, narrowing along the right ACA produced significantly higher time-
average maximum-mean velocities in mice afflicted with SCA. This work has laid the 
framework for determining potential biochemical mechanisms in SCA that are altering the 
cerebrovascular geometry and inducing elevated blood velocities, as well as enabling 
methods for testing future therapeutics. 
 
1 
CHAPTER 1  INTRODUCTION 
1.1 Motivation 
 Individuals with sickle cell anemia (SCA) have a risk of stroke with children 
between the ages of 2 and 8 at the greatest risk [1, 2]. Approximately 11.5% of adolescents 
with SCA will have an overt ischemic stroke before the age of 18 a 221-fold increase to 
age matched non-sickle counterparts [2]. Additionally, up to 37% of children by 14 years 
of age will have a silent stroke, which can go undetected for years but impair mental 
function and cognitive abilities [3]. Currently, transcranial doppler (TCD) is the only 
technique used to diagnose stroke risk, by measuring blood flow in the cerebral arteries. 
Elevated time-average maximum mean velocities (TAMMV) exceeding 200 cm/s in the 
internal carotid (ICA), middle cerebral (MCA), or anterior cerebral arteries (ACA) are a 
strong indicator of stroke risk in SCA [1]. More than 60% of individuals who have 
surpassed this threshold will develop a stroke within 3 years of diagnosis if left untreated 
[1]. Cerebral angiograms of individuals who have suffered from strokes have shown that 
the occurrence of stenotic lesions in the cerebral arteries [4, 5]. Characterization of these 
stroke lesions have shown remarkable vascular remodeling characterized by intimal 
hyperplasia and luminal narrowing [5], but it is unclear how such accelerated remodeling 
is occurring in children with SCA. While it is expected for high centerline velocities to 
occur through stenotic regions in arteries, morphological abnormalities are not always 
detected by angiogram despite TCD measurements indicating elevated velocities [6]. 
Therefore, analyzing the relationship between the geometry and hemodynamics is crucial 
to understanding the potential biomechanical mechanisms causing accelerated stroke 
development in SCA.  
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 Computational fluid dynamics (CFD) offers a powerful tool for investigating the 
cardiovascular system. Based on numerical approaches that use equations derived from 
physics to simulate blood flow, hemodynamic forces can be approximated in regions where 
traditional tools are ineffective, and thus can be used investigate the biological processes 
that are occurring. Wall shear stress plays an important role in cardiovascular health, with 
low and oscillatory shear inducing endothelial dysfunction and initiating the early stages 
of vascular remodeling [7-9]. Known to occur at specific regions of the cardiovascular 
system, such as bifurcations a dynamic cycle is created where the geometry affects the 
hemodynamics, which then affects the biochemistry that in turn affects the geometry [10]. 
This thesis investigates the effect of sickle cell anemia on the vascular geometry in order 
to understand the hemodynamics of stroke risk. 
 
1.2 Research Objectives 
 The objective of this research is to identify and validate flow-mediated 
mechanisms of accelerated cerebrovascular remodeling predisposing children with sickle 
cell anemia to strokes. Therefore, the central hypothesis is that the pathophysiology in 
sickle cell anemia changes the cerebrovasculature, altering the hemodynamics and 




1.2.1 Specific Aim 1: Investigate geometric scenarios sufficient to recapitulate the 
hemodynamic profiles of children with sickle cell anemia at risk for stroke 
Hypothesis: Elevated velocity profiles in children with sickle cell disease are generated 
from remodeling of the cerebral vascular anatomy.  
Researchers often study the hemodynamics of the microvasculature in relation to sickle 
cell anemia. This creates a gap of knowledge in the large artery system where abnormal 
velocity profiles also exist. Two- and three-dimension computational models were used to 
investigate the hemodynamics in sickle cell anemia. In the 2D model, the characteristics 
for sickle blood were investigated in order to determine appropriate properties for 
simulating blood flow in SCA. Additionally, the impact of stenoses were examined to 
elucidate the magnitude required to produce abnormal velocities associated with stroke 
risk. In 3D, patient specific models were generated from magnetic resonance angiograms 
of individuals with and without SCA to determine the impact of geometry in producing 
elevated velocities associated with stroke risk.  
1.2.2 Specific Aim 2: Investigate the hemodynamics and morphology in the carotid 
and cerebral arteries of a sickle cell transgenic mouse model. 
Hypothesis: Sickle cell anemia causes changes to the cerebral vascular anatomy that 
produce elevated velocity profiles.  
 Mouse models can be powerful tools used for investigating cardiovascular diseases, 
however it is unknown if the hemodynamic abnormalities observed in humans with SCA 
also exist in murine counterparts. Using the Townes sickle cell transgenic mouse model, 
cerebral blood flow was examined in homozygous sickle (SS) and heterozygous sickle 
(AS) mice. Blood flow cannot be directly measured in the cerebral arteries of mice; 
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therefore, a computational model was developed to approximate cerebral blood velocities. 
Subject specific boundary conditions were acquired using a combination of ultrasound 
imagining and vascular casts. Velocities in the common carotid and internal carotid arteries 
were measured using high-frequency ultrasound and used as an inlet boundary condition 
for the computational model. To obtain subject specific geometries, an insilico model was 
created from micro-computed tomography images of a casting created by injecting a radio-
opaque polymer into the cardiovascular system. The model was validated through 





CHAPTER 2  BACKGROUND 
2.1 Sickle Cell Anemia 
 Sickle cell anemia (SCA) is of the most common genetic blood disorders in the 
world. More than 300,000 babies are born each year with SCA, and approximately 4 
million worldwide are afflicted with the disease [11]. In the US alone, 100,000 people have 
SCA, which incurs a healthcare cost in excess of $1 billion US dollars annually [12, 13]. 
Life expectancy is also significantly reduced in males and females with SCA, living to an 
average of only 42 and 48 years of age, respectively [14].  
 Sickle cell anemia and sickle cell disease (SCD) are caused by a mutation in β-
globin, a subunit of the hemoglobin protein. The sickle or “S” mutation in β-globin is 
denoted as HbS, as opposed to the normal β-globin gene referred to as HbA. The term 
“sickle cell disease”  is an umbrella term that includes sickle cell anemia, which is defined 
as homozygous sickle (HbSS or SS), sickle trait (SCT) (HbAS or AS), and other sickle 
variant diseases that are combinations of HbS with another abnormal β-globin protein, for 
example HbC, HbD, HbE [15]. HbS is a single point mutation that changes a codon from 
GAG to GTG, and results in a negatively charged glutamic acid being substituted by a 
neutral charge valine, in the sixth position of β-globin [16]. In arterial circulation where 
the oxygen concentration is high, hemoglobin cooperatively binds and carries oxygen 
inside red blood cells. The protein conformation when carrying oxygen shields valine from 
the surrounding aqueous environment in the cytoplasm of RBCs; however, upon entering 
the capillaries a gas exchange occurs that leads to the release of oxygen, and results in a 
conformational change that exposes the hydrophobic valine to the surrounding aqueous 
environment. Under these conditions the hemoglobin molecules polymerize causing the 
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formation of a fibrous precipitate that change RBCs into the classical “sickle” shape for 
which the disease is known.  
 During sickling the overall RBC density, viscosity, and stiffness increase, which 
also increases the viscosity of whole blood by as much as 3-7 times at an equivalent 
hematocrit to individuals without SCA [17-20]. The sickling process also causes increased 
RBC lysing in individuals with SCA leading to lower levels of hematocrit (25%) as 
compared to those people without the genetic disease (45%) [17-20]. The repetitive 
polymerization and melting of hemoglobin fibers in the RBCs as they travel throughout 
oxygenated and deoxygenated circulation cumulatively damage the membrane, leading to 
the formation and existence of irreversibly sickled cells, which can make up as much as 
30% of the blood in the arterial system and ultimately change bulk flow properties in 
unexpected ways [21, 22]. Continuous damage to RBCs eventually leads to lysing as the 
cell life span is reduced from a normal 120 to 20 days [23]. This reduction in RBC numbers 
are associated with the anemia commonly associated with SCA. Individuals with sickle 
trait are generally regarded as having a benign form of the disease [24]. This is because 
HbA is also produced which dilutes the total amount of HbS in the cell and reduces the 
chance of hemoglobin polymerization. There have been reports however of complications 
for individuals with SCT from lack of oxygen, produced either from over exhaustion [25] 
or a high-altitude environment [26]. 
One of the more characterized complications in SCA is impaired blood flow 
culminating in occlusive events occurring throughout the vascular tree, from the relatively 
low-shear post-capillary venules to the relatively high-shear large cerebral arteries [4, 13, 
27-29]. The major causes of altered blood flow are 1) altered sickle cell blood rheology, 2) 
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increased inflammation, and 3) cellular adhesion [13]. It is important to note however that 
there is a wide diversity in phenotypes among individuals as some people experience an 
almost benign disease [13]. The mechanism for heterogeneity in phenotypes are wildly 
unknown, but finding and understanding potential clinical predictors for severe prognoses 
may pave the way for improved patient management and development of new treatments 
[30]. 
Amongst the types of vaso-occlusions which occur in SCA, sickle cell crisis is one 
of the most well characterized. Red blood cells are highly deformable allowing cells to 
travel through the capillaries, which can have a diameter smaller than the size of a single 
RBC. For individuals without SCA this causes no issue, however in those with SCA the 
increased rigidity of RBCs created by the polymerization of hemoglobin can prevent the 
cell from deforming and cause occlusions in the micro-circulation. These blockages can 
cause severe debilitating pain, necrosis, and organ damage [14, 31, 32].  
2.2 Strokes in Sickle Cell Anemia 
Though a majority of vaso-occlusive problems occur in the capillaries and post-
capillary venules, SCA can also affect the large arteries. One of the most debilitating 
complications associated with SCA is the development of strokes in children. By the age 
of 18, 11% of adolescents will have an overt ischemic stroke, affecting key motor 
functions, with those between the age of 2-8 at greatest risk [3, 33]. Additionally, up to 
37% of children by 14 years of age will have a silent stroke, which can go undetected for 
years but impair mental function and cognitive abilities [3, 34]. Furthermore, after the first 
stroke, the risk of recurrent strokes is elevated significantly by as much as 50-90% [35, 
36].  
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 The Stroke Prevention Trial in Sickle Cell Anemia (STOP), led by Robert Adams 
and others in the late 90s has paved the way for diagnosing and treating individuals at risk 
for ischemic stroke [37-39]. Using transcranial Doppler ultrasound (TCD), they showed 
that elevated cerebral blood velocities were correlated to stroke risk. Specifically, when the 
time-average maximum-mean velocity (TAMMV) exceeded 200 cm/s in either the internal 
carotid artery (ICA), middle cerebral artery (MCA), or anterior cerebral artery (ACA), the 
measurement is diagnosed as abnormal. If left untreated, individuals above this 200 cm/s 
threshold, have a greater than 60% chance of developing a stroke within 3 years of 
diagnosis  [1, 40, 41]. A conditional range between 170-199 cm/s was also established as 
these patients had a high risk of converting to the abnormal velocity range [42].  
 Though 170 cm/s is considered the maximum cutoff for a normal velocity in 
individuals with SCA, this is still high in comparison to those without SCA. Normal ICA 
velocities in people without SCA range between 50-90 cm/s [37-39]. Elevated blood 
velocities not within the range associated to stroke risk can be related to anemia. Lack of 
oxygen caused by SCA requires increased blood flow to meet metabolic demands [37-39]. 
Increased cardiac output and reduction in cerebrovascular reserve have both been measured 
in individuals with SCA and hypothesized as mechanisms used to compensate for reduced 
blood oxygen availability.  
While these mechanisms may be related to ischemic stroke risk in SCA, additional 
pathologies are found in those who have suffered from a stroke. Several studies have shown 
the presence of large stenoses, via angiograms in the cerebral arteries of individuals with 
elevated blood velocities [28, 43]. This is consistent with studies of blood flow in the 
vasculature, where increases in velocity at constant flow rates are due to localized stenoses 
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[44]. Furthermore, autopsies performed in the 1970s on individuals with SCA who died 
from ischemic strokes showed lesions associated with intimal hyperplasia in the luminal 
space. Characterized by infiltration and proliferation of smooth muscle cells, and fraying 
of the elastin lamina, these lesions show many similarities to atherosclerotic plaques, but 
are void of the lipid deposition know to occur with atherosclerosis [4, 5, 43, 45]. Therefore, 
similar mechanisms may exist between sickle-mediated strokes and atherosclerosis. The 
process of intimal hyperplasia in atherosclerosis has a wealth of literature [46-49], which 
can provide insight into the pathophysiology of sickle-mediated strokes [4, 5, 43, 50]. The 
timescale for atherosclerosis however is in the order of decades, whereas sickle cell-
mediated strokes can occur within the first few years of life. Additionally, many cases have 
reported abnormal TCD readings, but with cerebral angiograms presenting no 
morphological anomalies [51].  Other mechanisms are required to explain the development 
of strokes in younger individuals with SCA. 
While the chance of ischemic stroke decreases with age, the risk of stroke in 
individuals with SCA remains a persistent problem. By the third decade of life, risk of 
hemorrhagic stroke greatly increases [52]. The cause for this change in stroke type is not 
fully understood, however studies have shown low blood hemoglobin and high leukocyte 
numbers to be associated with hemorrhagic stroke [52]. Upon reaching the fourth decade 
of life, a switch occurs again and the risk of ischemic stroke begins to dominate in 
individuals with SCA [52]. 
2.3 Current Therapies for Stroke in Sickle Cell Anemia 
 In addition to developing criteria for diagnosing stroke risk the STOP trial also 
established the practice of monthly blood transfusions as the gold standard for preventing 
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strokes [35, 53]. Performed as either simple or exchange transfusions 
(erythrocytapheresis), long-term RBC transfusions are still the most popular prophylactic 
therapy used today. It is predicted that children who receive monthly blood transfusions 
have a 95% of remaining stroke free [1, 54]. Additionally, chronic transfusions have been 
shown to prevent stenoses and reduce cerebral blood velocities, an effect which is lost once 
transfusions are stopped[1, 15]. Monthly blood transfusions; however, carry significant 
risks. These included an increased chance on infection, alloimmunization, and iron 
overload, which are all life-threatening and prevent transfusions from being widely used in 
the general sickle population [27, 55]. 
Hydroxyurea was the first FDA (Food and Drug Administration) approved drug for 
treating SCA and was recently approved for pediatric treatment in 2017 [15]. It is a 
ribonuleoside diphosphate reductase inhibitor that was first used for treating various blood-
related cancers. A beneficial effect of hydroxyurea is the production of fetal hemoglobin 
(HbF), a protein that is normally replaced by adult hemoglobin several months after birth 
[56]. Production of HbF reduces the concentration of HbS in red blood cells and prevents 
polymerization of sickle hemoglobin. Due to this benefit, treatment consisting of 
hydroxyurea has been shown to reduce the number of sickle crisis events [57]. In addition, 
the TWITCH (Stroke with Transfusions Changing to Hydroxyurea) trial found patients 
with abnormal TCD velocities who switched from chronic blood transfusions to 
hydroxyurea, were equally protected from strokes, but only in individuals without a pre-
existing history of vasculopathy [58]. Hydroxyurea is not a cure for sickle cell anemia as 
damage can still occur in the brain and other organs [59]. In addition, there are adverse 
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effects such as rash, headaches, and nausea, as well as concerns about unknown effects of 
long-term treatment [15, 32, 60].  
 The only cure available for sickle cell anemia is allogenic hematopoietic stem cell 
or bone marrow transplantation (BMT) [61, 62]. By replacing hematopoietic stem cells 
with those from a non-sickle donor, an individual will be able to produce normal adult 
hemoglobin. Benefits of BMT are decreased SCA-associated mortality and prevention of 
organ damage [62]. Infection, graft-versus-host disease, and graft failure are all potential 
life-threatening risks of BMT [60, 61]. Age is another risk factor as the 5-year survivability 
of patients who underwent BMT decreases past the age of 16 [63]. Therefore, the procedure 
is only offered to those with severe cases of SCA, such as people with previous histories 
of strokes or recurrent sickle crises. Additionally, donor availability is an issue of BMT; in 
the US it is estimated that only 20% of patients with SCA have a matched sibling, matched 
unrelated donor, or preserved cord bloods available [60, 64].  
 Gene therapies are now seen as the future of curative therapies for sickle cell anemia 
[65]. Through manipulation of the human genome scientist are pursuing to remove and 
replace the HbS mutation. This avoids many of the donor issues with allogenic BMT as 
stem cells from the patient can be taken and modified [15, 60]. 2017 marks one of the first 
successful gene therapies for SCA, where an anti-sickling β-globin variant was transferred 
using a lentiviral vector into a 13-year-old boy [65]. Recent breakthroughs with 
CRISPR/Cas9 show promise, but it is unknown when such treatments will reach the larger 
population [66-68].  
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2.4 Hemodynamics in Cardiovascular Diseases 
The endothelium is a monolayer of cells that line the inside of blood vessels and 
come in direct contact with blood. Comprised of endothelial cells this serves several 
important homeostatic functions, among which are its ability to act as a barrier, control 
vascular tone, respond to inflammatory cues, influence thrombosis, and modulate vascular 
remodeling [69]. Under normal conditions cellular interactions, chemical stimuli, and 
hemodynamic forces are all required for healthy endothelial function, however certain 
conditions can induce dysfunction. Endothelial dysfunction is a precursor of cardiovascular 
diseases, such as stroke, and considered a shift in the homeostasis of endothelial cells 
towards characteristics which are vasoconstrictive, prothrombotic, and/or proinflammatory 
[70]. 
Hemodynamic forces play a large role on vascular health, as the flow of blood 
continually applies mechanical stimulus on the endothelium. The role of hemodynamics 
on cardiovascular health was first theorized in atherosclerosis, where the pathology was 
observed to occurred preferentially at bifurcations in the vascular tree [7, 44, 71]. At these 
locations blood flow is disturbed, where the flow pattern is non-uniform and recirculates 
over time. This varies significantly from straight sections of the vasculature, where flow is 
ordered and unidirectional. Several hemodynamic forces act on endothelial cells, such as 
hydrostatic pressure and cyclic strain, but among these forces shear stress is most related 
to the movement of blood. Fluid shear stress is the tangential component of the frictional 
force created by the flow of a viscous substance such as blood. At the boundary of a wall, 
shear stress is defined as 
𝜏𝑤 =  𝜇?̇?(Equation 2.1) 
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Where µ is the viscosity of the substance and γ is the shear rate. For Newtonian substances 
the viscosity is constant and independent of shear rate. Blood is non-Newtonian with 
viscosity increasing at low shear rates, this is especially important in the capillaries, where 
the small diameter of the vessel forces RBCs to come in close contact with each other [44]. 
In sickle cell anemia, polymerization of HbS in red blood cells increases the viscosity of 
blood, which can ultimately change the shear stress acting on endothelial cells [72-74].  
In humans, along straight sections of the vascular, wall shear stress (WSS) ranges 
between 10-70 dynes/cm2 in the arteries and 1-5 dynes/cm2 in the veins. In the regions 
around bifurcations where atherosclerosis is known to occur, WSS will oscillate between 
±5 dynes/cm2 [44, 75]. Therefore, specific thresholds arise which inhibit or promote 
endothelial cell dysfunction [7-9, 76-78].  This was verified through in vitro experiments 
where the type of shear applied on endothelial cells would induce different phenotypes. 
For example, when high unidirectional shear is applied, endothelial cells will stretch and 
align along the direction of shear; whereas under low oscillatory shear endothelial cells 
have a random disorganized pattern and maintain a round appearance. The type of shear 
can also influence the expression of certain types of genes and proteins. One of the most 
well studied proteins is the upregulation of endothelial nitric oxide synthase (eNOS) under 
high shear, and down regulation under low shear [79-81]. eNOS synthesizes nitric oxide, 
which causes smooth muscles cells in the vessel wall to dilate and increase vascular tone. 
On the reverse side low shear stress can cause upregulation of endothelial cell adhesion 
molecules’ VCAM-1, ICAM-1, E-selectin [49, 82, 83]. Under these conditions there is an 
increased chance for white blood cells to adhere to the endothelium, promoting a 
proinflammatory environment and endothelial cell dysfunction. This process however can 
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be reversed by applying high unidirectional shear. Low shear also causes the upregulation 
of certain proteases, such as cathepsin K and cathepsin L [84, 85]. These proteases degrade 
elastin and collagen, matrix proteins that comprise the blood vessel. When these proteins 
are degraded, smooth muscle cells in the vessel wall undergo a phenotypic change [48]. 
The cells will begin to migrate into any available space which can lead to intimal 
hyperplasia and narrowing of the lumen. Such as what is observed in stroke lesions of those 
with SCA.  
2.5 Computational Fluid Dynamics in the Cardiovascular System 
 Computational fluid dynamics (CFD) is a powerful tool that can be used to simulate 
and approximate hemodynamic forces acting in the cardiovascular system [86, 87]. This is 
especially beneficial in areas where traditional medical devices are unable to make accurate 
measurements. CFD is a numerical approach that uses equations derived from physics to 
simulate fluid flow in a system of interest and approximate fluid properties. The basis for 




= ∇𝑃 +  𝜇∇2𝒗 +  𝜌𝒈 (Equation 2.2) 
Where v is fluid velocity, P is pressure, ρ is density, and g is gravitational forces. and These 
equations describe the motion of fluids in a system though Newton’s second law of fluid 
motion, and the different terms correspond to inertial, pressure, viscous, and external 
forces. Navier-Stokes is always solved with continuity equation (Eq. 2.3).  
𝑑𝜌
𝑑𝑡
+ ∇ ∙ (𝜌𝑣) = 0 (Equation 2.3) 
The Naiver-Stokes equations represents conservation of momentum, while the continuity 
equation represents conservation of mass. By solving for these equations, it’s possible to 
approximate the fluid velocity and pressure within as given system. However, transient 
problems and complex geometries require a numerical approach to solve these equations. 
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 There are several different approaches to performing CFD. Among these methods, 
discretization approaches are some of the most often used. The first stage prior to the actual 
simulation are the completion of several pre-processing steps.  This begins by defining the 
system or geometry of interest. Afterwards the region occupied by the fluid is discretized, 
or divided in smaller components, in a process known as establishing the mesh. Mesh size 
is critical as smaller sizes ensure higher accuracy, but at the cost of computational 
processing. Once the mesh has been created the system of equations, such as Navier-
Stokes, are defined. The last step prior to the simulation is defining boundary conditions. 
This specifies properties of the fluid, behavior of the fluid at specific boundaries or walls, 
and initial conditions if the problem is transient. After all these steps are complete the 
simulation is performed and solved in an iterative manner. To improve the computational 
efficiency, CFD-based problems are often run using parallel computing, which divides the 
system into several smaller components that can be performed simultaneously. Once the 
simulation is complete the resulting solution can be visualized and examined for further 
analysis using a post-processing program. 
 Blood is a mixture of cells, proteins, and other constituents that make up plasma, 
and when examined these components causes blood to act like a non-Newtonian shear 
thinning fluid. However, in most arteries shear rates exceed 10 Hz, and blood behaves 
similarly to Newtonian substances [44, 73, 88]. In this region of the cardiovascular system, 
whole blood has an approximate viscosity of 4 cP. and density of 1.060 g/cm3 [44, 88, 89]. 
In SCA, the individual RBCs are more viscous, but overall hematocrit of whole blood is 
lower due to lysing of the cells. Therefore, in high shear regions viscosity is similar 
between sickle and non-sickle individuals [72, 73].  
 At the walls of the artery a no-slip condition is often applied, which assumes 
velocity of the fluid at the boundary is equal to the velocity of the boundary itself. When 
simulating blood flow in the cardiovascular system, the vessel walls are often assumed to 
be rigid and velocity at the wall is zero. Realistically, vessels are often moving and diameter 
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changes throughout the cardiac cycle. This however adds increased complexity to the 
system of equations. In most regions of the vasculature, deformation of the wall does not 
significantly affect the velocity field, thus justifying the rigid wall assumption [90].  
 The heart pumps blood in a cyclic pattern, therefore blood is often simulated using 
a periodic function across several cardiac cycles. Inlets and outlets are the cross-sections 
at which the blood enters and exits the system. For inlets a velocity or pressure waveform 
measured from a patient is usually applied. Physiological waveforms are also desirable at 
outlets, but there are often difficulties obtaining accurate measurements from smaller 
downstream vessels. The Windkessel model can be used to overcome these problems [44, 
91, 92]. Based on principals from electricity, a relationship between pressure (P) and blood 
flow (?̇?) can be established for the entire cardiovascular system using a mechanical circuit 













 (Equation 2.4) 
As blood is pumped from the heart during systole, the downstream vessels act like a 
capacitor (C) storing the blood due to its elastic properties. In parallel to this capacitor a 
resistive element (R2) is placed to represent the loss of energy as blood travels though the 
arterioles and smaller vessels of the cardiovascular. Often a third element (R1) is added to 
this model to represent the impedance of blood flow due to the characteristic resistance of 







Figure 2.1: Three-element Windkessel model.  
The Windkessel is used to relate pressure and flowrate in the cardiovasculature using a 
system of resistances and compliances. R1 represents the characteristic vessel resistance, 
R2 represents peripheral vessel resistance, and C is peripheral vessel compliance.  
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 After the simulation is completed additionally hemodynamic parameters can be 
calculated through post-processing of the velocity solution. Wall shear stress can be 
derived by using the following equation 
𝑊𝑆𝑆 = 𝝉𝒘⃗⃗ ⃗⃗  =  𝝉 ∙ 𝒏 − (𝝉 ∙ 𝒏)𝒏 (Equation 2.5) 
where 𝒏 is the outward unit vector normal to the wall, and shear (τ) is defined as  
𝝉 =  𝜇(∇𝒗 + ∇𝒗𝑇) (Equation 2.6) 
Though wall shear stress is important to vascular health two additional parameters time-
average wall shear stress (TAWSS) (Eq. 2.7) and oscillatory shear index (OSI) (Eq. 2.8) 
can be derived to describe the wall shear stress throughout the entire cardiac cycle [7, 8]. 




∫ 𝝉𝒘⃗⃗ ⃗⃗  𝑑𝑡
𝑇
0
 (Equation 2.7) 
𝑂𝑆𝐼 = 0.5(1 −
| ∫ 𝝉𝒘⃗⃗⃗⃗  ⃗𝑑𝑡|
𝑇
0
∫ |𝝉𝒘⃗⃗⃗⃗  ⃗|𝑑𝑡
𝑇
0
) (Equation 2.8) 
where T is the length of the cardiac cycle. Both play an important role for vascular health. 
In one study performed by, Cheng et al.  the effect of in vivo alterations of shear stress 
showed TAWSS and OSI are both essential conditions for development of atherosclerosis 
in apoE-deficient mice [13].  
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CHAPTER 3  SICKLE CELL ANEMIA AND PEDIATRIC STROKES: 
COMPUTATIONAL FLUID DYNAMICS ANALYSIS IN THE 
MIDDLE CEREBRAL ARTERY 
3.1 Introduction 
Sickle cell anemia (SCA) is one of the most common blood disorders in the world 
with 300,000 babies born each year [11]; amongst them 11% of children with this genetic 
disease will have a major stroke by the age of 16 years; and up to 37% will have a silent 
stroke impairing mental function and cognitive abilities by age 14 [3, 34]. After the first 
stroke, the risk of recurrent strokes is elevated significantly to 50-90% [35, 36]. During the 
major clinical trial STOP, Transcranial Doppler ultrasound was used to measure the highest 
time averaged mean blood flow velocity in the internal carotid artery (ICA), middle 
cerebral artery (MCA) or the anterior cerebral artery (ACA). The study concluded that 
children had greater than a 60% chance of developing a stroke when time averaged 
maximum-mean velocities (TAMMV) were greater than 200 cm/s, deemed the abnormal 
range, but chronic transfusions could significantly reduce the risk of primary stroke [36, 
93]. Patients in the conditional range from 170-199 cm/s are at increased risk as well and 
have high probability of conversion to the abnormal range [42]. The mechanisms that cause 
sickle cell-mediated strokes are still not fully understood but altered hemodynamics may 
be responsible as indicated by the elevated velocities. Deoxygenation causes a 
conformational change in the hemoglobin protein that exposes the mutant valine on the 
surface of the β-globin subunit that drives polymerization into stiff hemoglobin fibers that 
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deform the red blood cell (RBC) membrane into the sickle shape. The repetitive 
polymerization and melting of hemoglobin fibers in the RBCs as they travel throughout 
oxygenated and deoxygenated circulation cumulatively damage the membrane, increasing 
its viscosity and RBC density, which can ultimately change bulk flow properties in 
unexpected ways. RBC density, viscosity, and stiffness increase with each sickling, 
increasing viscosity of sickle cell blood by as much as 3-7 times greater than non-sickle 
blood at an equivalent hematocrit [17-20]. However, people with sickle cell anemia have a 
reduced hematocrit of only ~25% compared to 45% of those without the genetic disease. 
The interplay between the altered rheological properties induced by the sickle cells 
and the hemodynamics is not trivial and needs to be properly modeled with mathematical 
and numerical tools. While the change in shape and mechanical properties of the red cells 
alters the apparent viscosity, which should slow down the blood, the velocity in children 
with SCA is elevated. It is also worth pointing out that while it is expected to find elevated 
centerline velocities through stenotic regions of arteries, abnormalities may not be detected 
by MRAs although an elevated velocity is measured by TCD [51]. The objective of this 
study is to provide preliminary insight into these inconsistencies by determining in silico 
scenarios by which pathological, elevated blood velocities can occur in the MCA, ICA, 
and ACA of children with sickle cell anemia. Utilizing computational fluid dynamics 
(CFD), blood flow was simulated in both two- and three-dimensional computational 
reconstructions rendered from actual patient angiograms, then manipulated to determine 
virtual stenotic scenarios in the cerebral arteries capable of reproducing the elevated 
velocities measured by TCD to locate regions where stenosis may not yet be detected by 
magnetic resonance angiography. Further, these scenarios will provide key insight into 
 21 
hemodynamics that are counterintuitive to the general assumptions made about flow in 
tubes and at branches. Reconstructions from patients with and without sickle cell anemia 
were then compared for their hemodynamic properties to investigate inherent differences 
in geometry or anatomy that could be key to altering hemodynamics. This is the first work 
toward a progressively more accurate assessment of the rheological properties of patients 
affected by sickle cell anemia by using computational tools and their consequences on the 
hemodynamics. 
3.2 Methods 
3.2.1 System of Equations 
 The finite element method was implemented to simulate blood flow in the cerebral 
arteries. The commercial package, Comsol 4.4, and an open-source software, LifeV 
(www.lifev.org) were used to perform simulations in both two and three dimensions, 
respectively. The governing equations used for the study consisted of classical Navier-
Stokes equations for incompressible fluids (Eq. 3.1) and conservation principles of mass 
and momentum (Eq. 3.2). At this first level of investigation, we assumed blood to be an 
incompressible Newtonian fluid, such that viscous effects are explained by a constant 
viscosity 𝜇 multiplied by shear stress. By denoting with 𝒗 the velocity, 𝑃 the pressure, 𝜌 




= ∇𝑃 +  𝜇∇2𝒗 (Equation 3.1) 
∇ ∙ 𝑣 = 0 (Equation 3.2) 
where 𝐷/𝐷𝑡 denotes the material or Lagrange derivative, and ∇2 is the Laplace operator.  
 These equations were assumed to hold in the vascular lumen and delimited by the 
vascular walls and inflow/outflow sections. On the walls we postulate rigid displacement 
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and consequently assume a null velocity based on the no-slip condition. A zero-velocity 
and pressure were prescribed as the initial conditions for transient problems. However, 
since these conditions do not match the prescribed boundary conditions, this inconsistency 
may generate numerical instabilities. To avoid these spurious effects, before the actual 
simulation a “pre-load” phase is calculated, such that the initial conditions are gradually 
made consistent with the boundary data, by solving the Navier-Stokes equations for a 
certain number of fictitious time steps. At the end of this stage, the velocity and pressure 
fields at the beginning of the cardiac cycle are perfectly consistent with the prescribed 
boundary data. 
3.2.2 Characteristics and properties of two-dimensional simulations in COMSOL 
Arterial segments containing the distal internal carotid artery (ICA), the anterior 
cerebral artery (ACA), the middle cerebral artery (MCA), and segments from the first 
bifurcation of the MCA, known as the M2, were used for models in blood flow simulations 
(Fig. 3.1). These segments were chosen because of their diagnostic importance in 
determining stroke risk in sickle cell anemia by TCD [38, 94, 95]. The two-dimensional 
model was created from a representation previously published of a 71-year-old female 
subject (P0) [96], and used to perturb fluid properties, initial conditions, and stenoses 
placements (Fig. 3.1A). The representative figure was scanned into SolidWorks (Vélizy-
Villacoublay, France), where an outline of the model was produced and scaled to the 
appropriate size. A velocity waveform was prescribed at the inflow as illustrated in Fig. 3-
1B. These conditions are prescribed by postulating an arbitrary parabolic velocity profile 
fitted to the flow rate. To mitigate the impact of this arbitrary choice on the results, as 
common practice a flow extension was added upstream of the ICA [97, 98]. This fictitious 
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section has a length 10 times the diameter of ICA inlet. The mesh for the 2D simulations 
was created in Comsol (Stockholm, Sweden) using the program’s in-house mesh generator, 






Figure 3.1: Outline of two-dimensional cerebral artery model.  
(A) A 2D representation of the MCA from a 71-year-old female subject was used for the 
two-dimensional simulation. (B) Comparison velocity profiles over three cardiac cycles 
found in the ICA of SS and AA individuals. The elevated velocity profile caused by anemia 
in SCA was used as the inlet boundary condition for all simulations. 
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Simulated fluid properties were that of healthy blood (µ = 3 cP, and ρ = 1060 kg/m3) 
[44, 88, 89]. Flow extensions at the ICA-inlet were added to the original geometry to 
guarantee velocity profiles entering the ICA during the simulation were laminar and 
parabolic. The outlet arteries (ACA, M2-A, and M2-B) had an open boundary, and 
Comsol’s suppression algorithm was used to prevent backflow at the outlets, preventing 
the need for flow extensions at these arteries.  
Individuals with HbAA blood (RBC containing only normal hemoglobin) have a 
maximum-mean velocity of 40 cm/s in the ICA, based on values found in literature [99, 
100], therefore to simulate conditions in a person with HbSS blood (RBC containing only 
sickle hemoglobin), this maximum-mean velocity at the inlet was changed to 70 cm/s. This 
was based on values found clinically and represents the elevated blood velocities caused 
by anemia in an individual with SCA [38, 101]. After the maximum-mean velocity of the 
profile was increased, the rest of the waveform was scaled accordingly. These two velocity 
waveforms over three cardiac cycles are shown in Figure 3.1B.  
Simulations were run for three consecutive heart beats (1 Hz frequency) with a time 
step of 0.1 s. Post-processing of data for the 2D simulations were completed in Comsol. 
The maximum velocity during systole was determined across the entire model for all 
simulations, and the time-averaged velocity was calculated across cross-sectional slices at 
the proximal and distal ends of the MCA. Shear stress was calculated based on the 
following equation. 
𝝉 =  𝜇(∇𝒗 + ∇𝒗𝑇) (Equation 3.3) 
On the boundaries (walls), it is well known that the wall shear stress (WSS) has a clinical 
significance [44, 75]. The latter is defined as the tangential projection of the normal 
component of the shear stress, 
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𝑊𝑆𝑆 = 𝝉𝒘⃗⃗ ⃗⃗  =  𝝉 ∙ 𝒏 − (𝝉 ∙ 𝒏)𝒏 (Equation 3.4) 




Table 3.1 Parameter values used in finite element model 
 
Parameter Nomenclature Value 
ρ Density 1060 kg/m3 
ventr Average inlet velocity 70 cm/s 
dt Time Step 0.01s 
T Total Time 3s 
vint Initial Velocity 0 cm/s 




3.2.3 Non-Newtonian Model for Viscosity 
 Blood is a heterogeneous mixture composed of plasma, red blood cells, white blood 
cells, and platelets. This heterogeneous makeup attributes blood with the non-Newtonian 
properties of a shear thinning fluid that has its viscosity decrease when subjected to shear. 
In healthy individuals the red blood cell (RBC) volume or hematocrit accounts for 45% of 
the total blood volume [102]. The other main constituent of whole blood is plasma, which 
consists mostly of water, thus RBCs are the main contributor to blood’s non-Newtonian 
property. Blood rheology is affected by red cells in two ways: rouleaux formation at low 
shear rates and inelastic collisions at high shear rates [103]. In the large arteries, such as 
the MCA, the inelastic collisions will overtake rouleaux formation, as shear rates exceed a 
100 Hz [104, 105]. These non-Newtonian properties become especially important in the 
case of sickle cell where deoxygenation of the red blood cell leads to a conformational 
change in the mutated hemoglobin protein. This leads to polymerization of the β-globin 
into stiff hemoglobin fibers which deform the RBC membrane into the classical sickle 
shape [106]. Oxygenation of hemoglobin causes melting of the polymerized fibers, but the 
time required for this process can exceed the pulmonary circulation time, allowing for 
sickled RBCs to exist in the oxygenated systemic circulatory system [22, 106]. 
Additionally, repetitive polymerization and melting of hemoglobin fibers in the RBCs as 
they travel throughout oxygenated and deoxygenated circulation will cumulatively damage 
the cell membrane, producing an irreversibly sickled RBC with increased cell viscosity and 
density [21, 22]. This can ultimately change bulk flow properties in unexpected ways.  
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 An important feature that is overlooked when studying the viscosity of blood in 
sickle cell is the anemia associated with the disease. The accumulated damage from the 
sickling process shortens the RBC lifespan to only 10 days, reducing the total hematocrit 
from 45% to only ~25% [72, 106, 107]. Many of the initial studies investigating viscosity 
in SCA assumed equivalent hematocrits for HbSS (homozygous sickle) and HbAA 
(homozygous non-sickle) blood types, which lead to increased viscosity findings for HbSS 
blood which were 3-7 times greater than HbAA blood [73, 108, 109]. While the change of 
the shape and mechanical properties of the red cells increases the apparent red blood cell 
viscosity, conversely the decrease in hematocrit also lowers the total blood viscosity. Due 
to this information it is critical to analyze both HbAA and HbSS blood as non-Newtonian 
fluids in comparison to a traditional Newtonian model. This was accomplished by 
comparing results of a Newtonian simulation to those of a non-Newtonian simulation for 
both HbSS and HbAA blood types in a 2D model. The Carreau model [110-112] is one 
method that can be used to approximate blood as a non-Newtonian fluid. Based on the 
following equation: 
𝜇(?̇?) =  𝜇∞ + (𝜇𝑜 + 𝜇∞)[1 + (𝜆?̇?)
2]
𝑛−1
2  (Equation 3.5) 
 
Where µ∞ is the viscosity at a high shear rates, µo is the viscosity at low shear rates, is ?̇? 
the shear rate, and λ and n are model parameters specific to the fluid. Two different types 
of Carreau models were used for the simulations: (1) A sickle (HbSS) model with a 
hematocrit of 25% extrapolated from Alexy et al. (2006) [72], and (2) A non-sickle 








Table 3.2: Parameter Values used in non-Newtonian Carreau model 
 
Parameters 
HbSS Blood 25% Hct 
(Alexy et al. 2006) 
HbAA Blood 45% 
Hct (Chen et al. 
1970) 
µ∞ (cP) 3.431 3.966 
µo (cP) 131.7 103.2 
λ (s) 14.96 8.693 
n 0.2647 0.1898 




3.2.4 Characteristics and properties of three-dimensional simulations with VMTK, 
Netgen, and LifeV 
Magnetic resonance angiograms (MRAs) were used to create 3D models of the 
cerebral arteries for each subject (Fig. 3.2). Amongst the subjects, one did not have SCA 
(P1) (Fig. 3.2A), while the remaining two (P2 and P3) were afflicted with the disease. No 
identifying information was provided, other than P2 had no history of stroke (Fig. 3.2B), 
while P3 had a previous overt stroke that affected the left side of the brain (Fig. 3.2C). 
Using the reconstructive software, Vascular Modeling Toolkit (VMTK) [113], 2D MRA 
slices taken in the coronal plane were stacked together to produce a 3D layered object 
[114]. Arterial branches were segmented out from the layered object and used to 
reconstruct the vascular tree. Once the vascular network was created, only the segments of 
interest were kept, and all the other vessels were removed. Re-meshing and smoothing 
algorithms from VMTK were applied to remove irregular artifacts created during the 
reconstructive process. The finished models include flow extensions at the inlets and 
outlets with lengths equal to 10 times the diameter. Flow extensions have a twofold 
purpose. As for the 2D case, at inflow boundaries they are intended to take the effect of the 
arbitrary velocity profile used to compensate the lack of patient specific data away from 
the region of interest, so to mitigate (or even discard) its impact on the solution; at the 
outflow they are not strictly needed, but they contribute to reduce the risks of backflows – 
the latter are well known to be a source of numerical instabilities at outlets [115]. The flow 
extensions reduce the impact of the arbitrary choice for the velocity profile in the region of 
interest [116]. The third subject, P3, contains a slightly longer ICA due to a stenosis 
featured in that arterial segment. 
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A mesh of approximately 75,000 elements was applied to each of the three-
dimensional artery models. While for more accurate quantitative assessments, more refined 
meshes may be needed, at this preliminary qualitative stage of analysis, this mesh size is 
fine enough for a qualitative analysis of blood flow in view of comparative discussion. 
Meshes for the 3D simulations were first produced in the open-source software, Netgen 
[117] before being imported into LifeV [116]. The latter is an open source Object Oriented 
C++ Finite Element solver developed as a joint initiative of Department of Mathematics at 
EPFL, Lausanne CH, Department of Mathematics at Politecnico di Milano, Milan, IT and 
the Department of Mathematics and Computer Science at Emory University, Atlanta (GA) 
USA. The same SS velocity waveforms from 2D simulations were applied in 3D. 
Properties of Newtonian blood were assumed, and the artery walls were assumed to be 
rigid with a blood velocity of zero at the wall. In the 3D models, a lumped parameter (or 
0D) model was used at each individual outlet to relate the outgoing artery velocity to the 
pressure of the outlet, known as the 3-element Windkessel Model [118]. While not the 
same as the boundary conditions used in the 2-D model, by applying this boundary equally 
to all outlets, the resistances on the system acted similarly to the open boundary condition. 
Simulations were run in parallel on a local Linux cluster. The open-source software 
Paraview was used for postprocessing and for computing maximum systolic velocity. 
Average velocity was taken across cross-sectional slices at the proximal and distal ends of 
the MCA, using a custom script developed in Matlab (Natick, Massachusetts, USA) 
(Appendix 1) that integrated individual velocity points across a surface. Lastly, wall shear 




Figure 3.2: Reconstructed geometries of sickle and non-sickle cerebral arteries. 
Three-dimensional models were generated from MRAs of one non-sickle subject (P1) (A) 
and two sickle patients: one with no history of stroke (P2) (B), and another post-stroke 
(P3). (C) The model of Patient 3’s artery is extended due a stenosis in the ICA (arrowhead).  
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3.3 Results  
3.3.1 Viscosity of SS and AA blood do not differ in the middle cerebral arteries  
 After data points for the non-sickle and sickle Carreau models were extrapolated 
from literature, parameters for the model were fitted using the curve fitting tool in Matlab 
(Table 3.2). Both the HbSS and HbAA blood types had excellent fits with R2 value of 
0.9997 and 0.9963, respectively. Two-dimensional simulations were performed comparing 
the non-Newtonian models to a Newtonian model of healthy blood (µ = 3 cP, and ρ = 1060 
kg/m3) [119]. At high shear rates >10 Hz the viscosity for the Newtonian and all the non-
Newtonian models were found to behave similarly (Fig. 3.3A) with viscosities ranging 
between 3 and 4 cP at these high shear rates. Shear rates in the MCA and large arteries are 
greater than 10 Hz, thus based on these models, blood would behave as a Newtonian fluid 
[105]. Compared to HbAA blood, HbSS blood has a higher viscosity for shear rates below 
10 Hz, but a slightly lower viscosity for shear rates above 10 Hz (see magnified image in 
Fig. 3.3A), signifying that in the large arteries, SS blood has a lower viscosity than non-
sickle blood. These differences, however, did not greatly impact the hemodynamics in the 
large arteries.  
 Figures 3.3B-D depict the viscosity for each of the different blood models during 
diastole. Viscosity in the Newtonian model (Fig. 3.3B) is consistent throughout the entire 
geometry as expected. For the non-Newtonian Carreau models, the viscosity is highest 
along the centerlines and the inner curvature of bifurcations. Viscosity for the non-
Newtonian models range between 3 and 30 cP indicate shear rates in some regions were 
lower than 10 Hz. The viscosity of the SS and AA models are very similar with the SS 
model showing to have a slightly higher viscosity at bifurcations (Fig. 3.3C-D). Despite 
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the slight variations in viscosity between the models there are no distinguishable changes 
in the velocity profiles during systole (Fig. 3.3E-G), and the shear stress profiles during 
diastole (Fig. 3.3H-J), as compared to the non-Newtonian model. These suggest Newtonian 




Figure 3.3 Effects of Viscosity are Negligible in the Middle Cerebral Artery. 
Whole blood was simulated as a non-Newtonian fluid through the Carreau model in the 2D 
simulations. (A) Two non-Newtonian models were utilized in the simulation: (1) a HbSS 
Blood Model with a hematocrit of 25%, and (2) a HbAA Blood Model with a hematocrit 
of 25% were compared to a Newtonian model of blood. (B-D) The viscosity of the fluid 
during diastole is displayed in the top right panel. (B) Viscosity in the Newtonian model is 
constant for the whole model. The viscosity in the non-Newtonian models are higher along 
the centerlines and inner curvature of bifurcations. Viscosity is highest in the sickle model 
(C) followed by the non-sickle model (D). Between the Newtonian and non-Newtonian 
models, no noticeable differences are observed in the velocity profiles during systole (E-
G), nor in the shear stress profiles during diastole (H-J).  
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3.3.2 MCA-elevated velocities indicative of stroke risk could not be generated in a 
two-dimensional computational fluid dynamic model. 
First, we tested the hypothesis that an elevated velocity profile at the ICA-inlet caused 
by anemia would be sufficient to produce time-averaged mean velocities in the MCA 
greater than 200 cm/s, the magnitude that is indicative of stroke risk. Despite elevated inlet 
velocities approximately 40% greater than individuals with AA blood, the velocities in the 
MCA only reached a maximum speed of 90 cm/s during systole (Fig. 3.4A). Diastole 
values were of course lower, reaching only a maximum of 40 cm/s. Under these conditions, 
higher fluid velocities were observed in the ACA (100 cm/s) as compared to the MCA.  
Since the elevated inlet blood velocity was insufficient to generate threshold velocity 
values indicative of stroke risk, shear stress was determined to identify regions of low or 
oscillatory shear stress. Such regions are known to cause endothelial cell responses that 
promote proteolytic mediated vascular remodeling leading to the formation of intimal 
hyperplasia that could possibly form stenoses in the artery [76, 77, 120]. Wall shear stress 
values were calculated from the velocity profiles, and areas of the artery wall exposed to 
shear stress in the range of ± 5 dynes/cm2 are found to occur preferentially along the inner 
curvature of bifurcations (Fig. 3.4B). The length of the wall region exposed to this low, 
and in some cases oscillatory shear stress is shorter in systole than diastole.  
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Figure 3.4 Elevated internal carotid artery velocities caused by sickle cell anemia 
does not generate velocities greater than 200 cm/s in the middle cerebral artery. 
Velocity and shear stress profiles were calculated for a 2-D arterial model with the 
TAMMV of the ICA inflow velocity set to those of a patient with SCA (70 cm/s). (A) 
Velocity profiles during systole and diastole. Velocity was highest in the ICA and ACA, 
and the maximum velocity in the MCA did not exceed 90 cm/s. (B) Regions of low wall 
shear stress during systole and diastole are depicted with a maximum threshold of ± 5 
dynes/cm2. The affected regions correlate to regions with low velocities (A) and include: 
the apex of the terminal end ICA bifurcation and inner curvature of bifurcations. 
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3.3.3 Effects of stenosis placement and size on velocities in the MCA 
The original model was modified to simulate the development of intimal 
hyperplasia and vascular lesions that would occur at sites exposed to low wall shear stress, 
and these regions were informed by the sites of low wall shear stress from the previous 
model (Fig 3.4B). To test the hypothesis that stenoses formed by such lesions could 
produce an elevated time-average maximum-mean velocity greater than 200 cm/s, vascular 
lesions were placed one at a time, in either the ACA, the proximal MCA, the M2-A, or the 
M2-B. This was to determine the percent stenosis necessary to generate elevated velocities. 
Simulations were performed over a range of stenosis magnitudes: 25% (green), 50% 
(orange), or 75% (red) of the artery diameter (Fig. 3.5A).  
The mean velocity was calculated at the proximal and distal ends of the MCA, and 
the effects of stenosis magnitude and location on mean blood velocity in the proximal and 
distal MCA were determined. As the magnitude of a stenosis in the MCA increased from 
0% to 75% the artery diameter the mean velocity also increased in the proximal MCA, 
reaching a maximum-mean velocity of about 90 cm/s (Fig. 3.5B). A similar effect was 
observed when a stenosis was placed in the ACA; however, the velocity at the proximal 
MCA only increased from stenoses sizes ranging between 50% and 75%, and 25% lesions 
having little to no effect on blood velocities at proximal MCA site (Fig. 3.5C). Stenoses in 
both the M2-A and M2-B had minimal effect on velocity in the proximal MCA despite 
large stenoses that filled 75% of the artery diameter (Fig. 3.5D&E).  
Stenosis placement in the ACA and the downstream arteries of the MCA, the M2-
A and M2-B had similar effects on velocity calculated at the distal MCA site (Fig 3.5G-I), 
but when the stenosis was placed at the entrance to the MCA, the results were significantly 
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different (Fig. 3.5F). There was a decrease in mean velocity at the distal MCA site from 60 
cm/s to 25 cm/s which was opposite of what occurs to velocities measured at the proximal 
MCA location. Taken together, the data could be plotted as percent change in the 
maximum-mean velocity to distinguish differences between velocities at the proximal or 
distal end of the MCA (Fig. 3.5J-M). Only for stenoses placed at the entrance of the MCA, 
can a stark difference in maximum-mean velocities be generated along the length of the 
MCA (Fig. 3.5J). The percent change in velocity increased as a function of percent stenosis 
for velocities measured at proximal MCA, but conversely decreased with percent stenosis 
at the distal end. This has important implications for determining patient stroke risk. It 
could be, that when averaging velocities measured by TCD over the length of the entire 
MCA, an incorrect and significantly lower velocity reading might be obtained, misleading 
clinicians to thinking the patient is safe, although a large stenosis may be present, and the 
patient is at high risk. Despite this interesting disparity for proximal MCA lesions, the mean 
MCA velocity never exceeded a 100 cm/s, regardless of lesion size and location. 
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Figure 3.5 A lesion at the entrance of the middle cerebral artery produces the 
largest difference in the proximal and distal velocities. 
(A) A lesion at the entrance of the middle cerebral artery produces the largest difference in 
the proximal and distal velocities. Lesions of increasing size from 25% -75% of the artery 
diameter were placed in entrance of the MCA, ACA, MCA-1, and MCA-2 (areas affected 
by low WSS) in order to produce stenotic lesions. Dotted lines represent slices where the 
mean velocity was measured in the proximal (top panel) and distal (middle panel) MCA. 
Mean velocity in the proximal MCA increased with lesion magnitude when narrowing 
occurred at the entrance of the MCA (B) and ACA (C). (D, E) Lesions in M2-A and M2-
B had a negligible effect on velocity despite a lesion magnitude of 75%. (F) In the distal 
end of the MCA, the mean velocity decreased with increasing MCA stenosis. Increasing 
the magnitude of the ACA lesion led to an increased velocity in the distal MCA (G), and 
stenoses in the M2-A and M2-B did not affect velocity (H, I). In the bottom panel, percent 
change in the maximum-mean velocity was calculated in respect to lesion magnitude and 
location. (J) A lesion in the MCA entrance produced the greatest difference in percent 
change, increasing and decreasing in the proximal and distal MCA velocity, respectively. 
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(K- M) Lesions in the ACA, MCA-1, and MCA-2 entrances have the same effect on both 
the proximal and distal velocities. 
 
 
3.3.4 Mean Velocity is elevated in 3D patient-specific cerebral artery geometries of 
individuals with SCA 
The inability to reach high pathological MCA velocities indicative of stroke risk in 
individuals with SCA in the 2D simulations maybe due to a lack of features only available 
in three dimensions; therefore, the importance of using full 3D models were investigated. 
Three subjects were compared to determine if anatomical differences between sickle and 
non-sickle individuals could influence the hemodynamic properties.  ICA, ACA, and MCA 
vessels were reconstructed as described in the Methods sections from magnetic resonance 
angiograms (Fig. 3.2). Simulations were run with the same fluid properties and inlet values 
for all three subjects as in 2D.  
A slice of the velocity streamlines during systole are shown for each subject: (P1) 
non-sickle cell; (P2) sickle patient with no history of stroke; and (P3) sickle cell patient 
that had a previous stroke (Fig. 3.6A-C). Maximum velocities differ for each of these 
reconstructed cerebral artery trees with P1, the non-sickle subject maximum reaching 170 
cm/s in the ACA, up to 230 cm/s in the ICA of P3, the sickle patient post-stroke, and then 
the highest max value of 250 cm/s occurs in P2, the sickle patient no history of stroke 
(arrows, Fig. 3.6A-C). The velocity in the MCA remains consistent throughout the entire 
length of subject P1 (Fig. 3.6A). Velocity in the MCA of P2 gradually increased starting at 
120 cm/s at the proximal side before reaching a maximum toward the distal end (Fig. 3.6B). 
The velocity profile slowed across the length of the MCA for P3 with the proximal end 
reaching a maximum value of approximately 180 cm/s, and gradually decreased to ~90 
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cm/s at the distal MCA. Subject P3 also had a localized increase in velocity occurring at 
the stenosis in the ICA (arrowhead Fig. 3.6C). 
The mean velocities in the proximal and distal ends of the MCA were calculated 
for each subject. Subject P1 had the greatest consistency across the length of the MCA with 
the proximal end reaching a TAMMV of 72 cm/s and the distal end as high as 90 cm/s (Fig 
3.6D). Subject P2 had the largest variance between both ends of the MCA. The proximal 
MCA was much lower reaching 66 cm/s, but the distal end had a maximum-mean velocity 
of 140 cm/s. A stenosis right at the bifurcation to the M2-B that may be the cause for this 
increase (Fig 3.6E). P3 fell in between the other subjects, for both velocity and maximum 
speed and variance in the MCA. This subject had a TAMMV of 92 cm/s and 61 cm/s for 
both the proximal and distal ends respectively (Fig 3.6F).  
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Figure 3.6: Velocity profiles in the middle cerebral are elevated in individuals with 
sickle cell anemia. 
Slices of the velocity streamlines are depicted for each subject during systole. (A) The 
maximum velocity in the non-sickle patient (P1) is highest in the ACA (arrow), and the 
MCA presents a consistent profile that peaks at ~150 cm/s. (B) In the sickle patient with 
no stroke (P2), the velocity is highest in the MCA (arrow), increasing from the proximal to 
the distal end with a maximum speed of 251 cm/s. [C] The sickle subject with a previous 
history of stroke (P3) has the highest velocity occurring along the ICA prior to the 
bifurcation (arrow) and at the stenosis (arrowhead). The maximum velocity in the MCA 
reaches approximately 180 cm/s at the proximal end and decreases towards the distal MCA 
bifurcation. (D) The velocity in the MCA of P1 has the least variance with the velocity at 
the proximal and distal ends reaching 72 and 90 cm/s, respectively. (E) The velocity profile 
in the MCA of P2 has the largest variance amongst all the subjects with velocity increasing 
from the proximal end at 66 cm/s to the distal end at the 141 cm/s.  (F) Subject P3 has its 




3.3.5 Areas of flow recirculation and low wall shear stress are more prevalent in 
reconstructed vessels of individuals with sickle cell anemia 
Post-stenotic regions are subject to flow separation and flow reversal during the 
cardiac cycle [121], which also impose oscillatory shear stress on the endothelial cells 
lining the arteries that contributes to endothelial dysfunction and vascular remodeling [7-
9]. With identification of elevated velocity regions in the cerebral arteries of these three 
subjects due to their individual geometry differences and not unique fluid inlet profiles, we 
next determined where regions of flow separation and low shear stress could influence 
biological remodeling. Velocity streamlines for each subject during systole is displayed in 
Fig 3.7 to display areas affected by disturbed flow with particular interest in regions of 
flow separation and recirculation. Magnified images of flow recirculation (circles) and 
vortices (square) are labeled to distinguish the differences (Fig 3.7). Subject P1, the 
individual without sickle cells disease, did not show regions of disturbed flow (Fig 3.7A); 
however, subjects with SCA, P2 and P3, both demonstrated fluid recirculation along 
multiple locations despite given the same inlet profile as P1. The sickle subject with no 
history of stroke (P2) had regions of recirculation along the inner curvature of bifurcations 
in the ACA, MCA and M2-A (Fig 3.7B). Subject P3, sickle post-stroke, had regions of 
flow recirculation at MCA along the inner curvature of the ICA bifurcation, and at the ICA 
stenosis (Fig 3.7C).  
In addition to velocity, the wall shear stress (WSS) profiles were calculated during 
diastole. Areas of low shear stress (±5 dynes/cm2) appeared near the recirculation zones, 
as expected (Fig 3.8). Front and back views of the model for subject P1 show areas of low 
shear stress to be located at the apex of the internal carotid bifurcation (Fig 8A). In both 
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subjects with SCA (P2 and P3), regions of low WSS were found in multiple locations that 
encompass a larger area as compared to the non-sickle subject. In the first individual with 
SCA (P2), regions of low WSS occurred along the inner curvature of the ICA and MCA 
bifurcations at the ACA, MCA, and M2-A (Fig 3.8B). Subject P3 had regions of low WSS 
along the ICA and MCA arterial segments (Fig 3.8C).  
 
Patient-specific velocity streamlines during systole are depicted for the 3-D 
vascular models with recirculations (circles) and vortexes (squares) magnified for easier 
viewing. (A) The non-sickle subject’s (P1) artery is completely void of any regions of fluid 
recirculation. (B) The first sickle subject (P2) has fluid recirculating at multiple locations 
near the inner curvature of bifurcations: specifically, at the ACA (1), MCA (2), and M2-A 
(3) arterial segments. A vortex is observed in the M2-B segment (4). (C) The second 
subject has recirculations occur at the ICA stenosis (1), and the MCA (3) following the 
ICA bifurcation. Vortexes are observed along the ICA (2) and at the MCA bifurcation (4). 
Figure 3.7: Recirculation of velocity streamlines are more prevalent in SCA 
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Figure 3.8: Areas of low shear stress are greater in sickle cell anemia arteries. 
Low WSS (±5 dynes/cm2) during diastole were calculated from velocity profiles of non-
sickle and sickle subjects. The locations of these low WSS (circles) are magnified in the 
images to the right for easier viewing. (A) In the non-sickle subject (P1), two spots of low 
stress areas of low shear stress occur at the apex of the internal carotid bifurcation (1). (B) 
The sickle subject with no history of stroke (P2) has regions of low WSS occur along the 
inner curvature both bifurcations in the ACA (1), MCA (2), M2-B (3), and M2-A (4). (C) 
The second subject (P3) has multiple regions of low WSS. Two occur in the ICA, first at 
the stenosis (1), and then preceding the ICA bifurcation (2).  Low shear areas also occur 
along the length of the MCA, one following the ICA bifurcation (3), and the other at the 




 The maximum velocities measured in the 3D simulations ranging between ~180 
and 250 cm/s were much higher than in 2D, where only a max velocity of 100 cm/s was 
achieved. The 3D models therefore offered a better representation of the fluid profiles. 
While none of the mean velocities surpassed the 200 cm/s threshold value indicative of 
stroke risk, velocities in the simulations created from individuals with sickle cell anemia 
(P2 and P3) were higher than the reconstruction from an individual without SCA (P1). 
Therefore, despite the same boundary conditions across all simulations, the patient-specific 
geometries were sufficient to produce elevated velocities. This is an important result given 
that only a percentage of children with sickle cell anemia will have a major or silent stroke; 
the patient-specific differences responsible for this variability may include the individual 
anatomy.  
The mean velocity in the distal MCA for both sickle subjects P2 and P3, were 
greater than the non-sickle subject P1, and greater changes in magnitudes of the velocities 
occurred at the proximal vs. distal ends of MCA (Fig 4). In the proximal MCA the mean 
velocity for subject P2 was greater than the mean velocity for P1; however, the sickle 
subject P3 was the lowest. This lower velocity in the sickle subject may be due to the 
presence of a small stenosis occurring in the distal end of the artery.  Along the length of 
the MCA, subject P1 (non-sickle) had lower velocities, compared to SS subjects P2 and 
P3, (Fig. 3.6). This may be due to the surface texture of the endothelial surface in the 
arteries from sickle cell patients as they presented a “bumpy” appearance not seen in the 
non-sickle patient. These patient-specific geometries may be indicative of cellular or 
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pathophysiological phenomena that should be studied as causative phenomena for elevated 
velocities and stroke risk.  Autopsies of patients who passed away from strokes indicated 
vascular remodeling characterized by fragmented elastic lamina, intimal hyperplasia, and 
luminal occlusion [50, 122, 123]. The luminal narrowing may cause the high blood 
velocities indicative of stroke risk, but it is unknown if it acts as the main contributing 
mechanism to the pathology. Additionally, an array of other pathological mechanisms 
including, increased red blood cell (RBC) and leukocyte adhesion, inflammation, and 
increased viscosity of individual red blood cells may be responsible for the bumpy texture 
and also provide biological mechanisms to be investigated as novel mechanisms that 
accumulate to cause sickle cell - mediated strokes [28, 103, 124, 125]. 
Although the TAMMV of the MCA did not exceed 200 cm/s in the 3D simulations, 
subjects with SCA when compared to the non-sickle patient were found to have higher 
streamline velocities. Additionally, both individuals with SCA had altered hemodynamic 
profiles, characterized by greater regions of flow reversal (Fig. 3.7) and large areas affected 
by low WSS (Fig. 3.8). These regions of low shear stress also correlated to zones of fluid 
recirculation, and occurred preferentially at the inner curvature of bifurcations or following 
stenoses, as seen in subject P3, corroborating findings from the atherosclerosis literature 
and previous studies [44, 75, 126]. Subjects with SCA were affected by low shear stresses 
over a larger surface area compared to the non-sickle patient, indicating that those 
individuals may be subject to shear stress mediated vascular remodeling. This result also 
illustrates the power of computational fluid dynamics as shear stress cannot be directly 
measured. Computational fluid dynamics could potentially be used to predict stroke risk 
by allowing clinicians to look for signs of altered blood flow, as these abnormal 
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hemodynamic forces may precede large stenosis formation that can cause high streamline 
velocities. Vascular remodeling may precede stroke formation, but it can sometimes be 
difficult to detect such small vascular changes with MRA. Unfortunately, radiological 
findings of large stenoses often coincide with stroke, as seen in subject P3, and preventative 
measures cannot reverse the damage. More simulations will need to be performed in the 
future to show statistical significance correlating disturbed flow profiles to stroke risk, but 
these current results show promise.  
 Higher MCA velocities could be achieved in silico by manipulating the ICA-inlet 
boundary condition, as the 70 cm/s maximum velocity chosen for this study was the lowest 
measured value acquired from a sickle patient in a cohort of six individuals. In general, 
sickle patients will have higher velocities as caused by anemia [37, 38]. Thus, the lower, 
but still elevated value of 70 cm/s, was deemed an appropriate input value for this study. 
An interesting phenomenon observed in the 2D stenotic simulations and in both 3D sickle 
models was the occurrence of a velocity gradient, which varied along the length of the 
MCA. This finding poses a question on the precision of TCD and the potential for 
misdiagnosis. Currently, TCD cannot perform the precise measurements taken from the 
simulations, as averages are taken across an area which can spans a width of 4 mm to 1.5 
cm [127]. Measurements typically are made at 2-mm intervals, and thus only approximate 
values that extend over an entire arterial segment. This can potentially lead to incorrect 
diagnoses, as localized regions with high elevated velocities are in the same frame of 
measurement as regions with significantly lower velocities.  
This study does have limitations. In particular, geometries are rigid, we do not have 
patient specific boundary conditions, and viscosity is assumed to be constant and tuned to 
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literature values. Results from non-Newtonian simulations suggest that in the large arteries, 
specifically in the MCA and its adjacent branches, Newtonian AA blood can be used in a 
sickle model. Utilizing this assumption in the sickle model greatly reduced the 
computational complexity and increase the speed of simulations. It is important to note that 
these assumptions can only be applied in the large arteries as the contribution of each 
individual RBC becomes increasingly more important in the smaller vessels. Known as the 
Fareus-Lindqvist effect the viscosity of healthy blood decreases with vessel dimeters 
ranging between 10 and 400 microns [128]. This is because erythrocytes will move to the 
center of the vessel leaving only plasma at the wall. Sickle cell anemia hinders this effect 
as the reduced elasticity and increased viscosity of each individual RBC prevents 
deformation of the cell through the microvasculature. If velocity through the 
microvasculature is reduce significantly because of these effects the shear rate in vessel 
will drop and cause rouleaux formation to occur [103]. The red blood cells will begin to 
aggregate at these low shear rates and block blood flow causing the ischemia that is often 
associated with sickle crisis.  
After this qualitative assessment, we plan to perform a campaign of numerical 
simulations – possibly with patient-specific boundary data and certainly with more refined 
meshes - for a more quantitative analysis of the interplay of rheology and fluid patterns. 
The follow up of the study is exactly to retrieve pediatric data of sickle vs. non-sickle age-
matched geometries, and reproduce the results obtained here with a precise quantitative 
assessment. The ultimate goal is to find a precise correlation between the altered 
rheological properties and the stroke risk in young people with sickle cell anemia. As for 
the rheological models, another important aspect of CFD is the solution of rigorous data 
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assimilation problems for a patient-specific quantification of apparent viscosity in diseased 
patients. This means that we systematically compare numerical results with available 
measures for different values of the viscosity to find the value that best describes 
measurements. This can be done by performing rigorous numerical procedures of what is 
called “variational data assimilation” [129-131].  
 Currently, few researchers are examining the fluid dynamics in large arteries 
associated with sickle cell anemia, and the difficulty in doing so is not minimal. Blood 
rheology is affected by red cells in two ways: rouleaux formation at low shear rates and 
inelastic collisions at high shear rates [103]. The altered shapes, density, and membrane 
viscosity, and associated variability among the RBCs in sickle cell anemia as they progress 
from reticulocytes to irreversibly sickled cells over the 9-10 days of their lifespan [106], 
probably affects both of these aspects. The impact of the shape on the effects of the 
collision (with consequent altered energy balance) may require some sophisticated 
rheology based on differential models. However, all these models require the quantitative 
tuning of many parameters (beyond the viscosity) which at this stage is out of reach. There 
are investigations of the cerebral anatomy in the MCA and ICA by other groups, and they 
have found tortuosity to be implicated in stenosis formation [132]. This is interesting to 
note as certain tortuosity and curvature has been associated with aneurysm formation and 
rupture [133]. As demonstrated in this paper geometrical differences in the arteries 
themselves between sickle and non-sickle individuals can have drastic effects on the 
hemodynamics. Quantifying these differences may allow clinicians to predict patients who 
are at risk of stroke prior to the elevated velocities used currently, enabling patients to get 
treatment sooner. 
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CHAPTER 4  AGE-DEPENDENT CHARACTERIZATION OF THE 
CAROTID AND CEREBRAL ARTERY MORPHOLOGIES IN 
A TRANSGENIC MOUSE MODEL OF SICKLE CELL 
ANEMIA 
4.1 Introduction 
Sickle cell disease (SCD) is one of the more prevalent blood disorders worldwide 
with more than 300,000 new individuals born each year afflicted by the disease. Sickle cell 
anemia (SCA), specifically, is caused by a missense mutation that substitutes glutamic acid 
for valine in hemoglobin. This change in molecular structure causes the hemoglobin in red 
blood cells (RBCs) to polymerize and aggregate under de-oxygenated conditions, leading 
to deformation and increased rigidity of the cell that cause blockages in the 
microvasculature that can damage organs and lead to painful episodes known as sickle 
crisis. SCA also has effects on the large arteries, most notably in the elevated occurrence 
of strokes in individuals with SCA.  
The chance of ischemic stroke is greatly elevated for young individuals with SCA, 
occurring in 11% of people between the ages of 2 and 18 [33].  Then, during ages 20-30, 
the risk of ischemic stroke falls, but is replaced with an increased risk of hemorrhagic 
stroke. Upon reaching early to mid-30s, the risk of ischemic stroke begins to dominate 
again in individuals with SCA [52]. Age is an important factor for sickle cell-mediated 
strokes, and mechanisms behind variations in types of strokes during specific times of life 
with SCA are unknown. Some clues can be extracted from investigating the vascular 
morphology. In individuals who have suffered ischemic strokes, cerebral angiograms have 
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shown the presence of stenosis [28, 43, 50]. Additionally, autopsies of individuals who 
have died from sickle-related strokes, show defined markers of intimal hyperplasia [4, 50]. 
In order to provide insight into underlying structural changes that affect stroke risk 
in relation to age, mouse models can be used. The murine cerebral circulation displays 
similarities to humans; the brain is supplied by a pair of vertebral and carotid arteries that 
branch to form a network resembling the Circle of Willis (CoW) in humans [134]. The 
Townes sickle cell transgenic mouse model has been beneficial for investigating 
pulmonary and hematological pathophysiology [135-137], with a few studies on 
cerebrovascular complications of SCA [138-143]. These studies however have not 
investigated changes to the cerebral vascular anatomy, specifically in the arteries 
associated with stroke risk.  
The goal of this study is to determine how morphology of carotid and cerebral 
arteries change as the mice age, and any differential effects caused by sickle cell anemia. 
In a cross-sectional study, we use a combination of ultrasound and microcomputed 
topography (micro-CT), to determine morphometries of carotid and cerebrovascular 
arteries of Townes mouse model. Both techniques have distinct advantages and 
disadvantages, which, when combined, can provide a comprehensive morphometric 
characterization. Ultrasound in living mice allows for longitudinal studies that can be used 
to obtain arterial dimensions during systole and diastole. However, murine vasculature is 
much smaller than humans, with vessels approximately 1/30th the size introducing 
limitations in resolution and access to arteries in the skull [144-146]. Alternatively, 
advances in micro-CT imaging procedures for small animal models through the use of 
perfused contrast agents have enable researchers to investigate structures within a voxel 
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size of 8 µm [147, 148]. For these reasons, we also used micro-CT on casts of the carotid 
and cerebral arteries in mice. Casts were created by a plastination method using a 
radiopaque polymer that hardens in the vessels. This cast was then scanned by micro-CT 
and reconstructed in silico to acquire morphological information of the smaller carotid and 
cerebral arteries. Casts of the arteries have their own tradeoffs in that it is an endpoint 
analysis, disallowing longitudinal studies from the same subject. These modalities were 
used to obtain detailed morphologies of the primary branches of the common carotid artery 
(CCA), internal carotid artery (ICA), middle cerebral artery (MCA), and anterior cerebral 
artery (ACA) of mice homozygous for human β globin S, the sickle cell allele (SS) or mice 
heterozygous for human sickle cell allele and wildtype β globin A allele (AS). Our results 
suggest sickle cell disease alters the vascular morphology in mice 12 and 24 weeks old, 
and these age-specific changes may be relevant for age-related risk of types of strokes.  
4.2 Methods 
4.2.1 Townes Sickle Transgenic Moise 
Townes sickle cell transgenic mice (Jackson Laboratories, Bar Harbor ME) were 
used for a cross-sectional study. This humanized knock-in model of sickle cell anemia was 
generated by knocking in the human hemoglobin genes (α, β, and γ), including the β-globin 
S mutation, into mice null for murine hemoglobin genes [135]. Mice homozygous for β-
globin S mutation (SS) were compared to littermate heterozygous (AS) controls. Three 
different ages were used for the study: 4-weeks, 12-weeks, and 24-weeks, with each age 
corresponding to a different risk and type of stroke risk in humans with SCA (Table 4.1) 
[52, 149].   Each age group consisted of 4-7 mice [4 weeks old (nAS = 6, nSS = 4), 12 weeks 
old  (nAS = 7, nSS = 4), 24 week (nAS = 4, nSS = 4)], and all mice were cared for at Peking 
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University (Beijing, China) using standard mouse caring techniques, and ethical protocols 
were followed based on the Institutional Animal Care and Use Committee of Peking 
University (Beijing, China).  
 
Table 4.1 Relation of mouse and human ages and types of stroke most likely to 








Most Likely Type of 
Stroke in Humans 
with SCA 
4 12.5 Ischemic 
12 20 Hemorrhagic 
24 30 Ischemic 
 
4.2.2  High Frequency Ultrasonography 
 Ultrasound measurements were performed in all mice using a VEVO 2100 Doppler 
system (VisualSonics, Toronto, ON, Canada) with a 22-55 Mhz transducer (MS550D, 
wavelength ~50µm – 2mm). Mice were anesthetized with 5% isoflurane on a horizontal 
platform in the supine position in order to monitor heart rate. Hair was then removed from 
the neck and pectoralis, before ultrasound gel (Aquasonic, Parker Laboratories) was 
applied to improve signal acquisition. After the specimen was secured to the platform 1% 
isoflurane mixed with oxygen is provided to maintain the anesthesia. The right carotid 
bifurcation was visualized in the sagittal plane with B-mode by applying the ultrasound 
beam perpendicular to the arteries, which were identified based on their depth from the 
surface of the skin, the direction of flow, and spatial orientation. A 2D recording was taken 
of the right carotid bifurcation over 2-3 seconds, and then the process was repeated for the 
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left side.  Dicom recordings were analyzed in ImageJ to determine arterial diameter during 
systole and diastole. Diameter was determined as perpendicular distance from the top to 
bottom of a vessel in the sagittal plane. Two measurements were taken to obtain an average 
common carotid artery diameter at 0.5 and 1.5mm upstream of the bifurcation. In the 
extracranial internal carotid artery, only one measurement could be taken 0.5mm 
downstream of the bifurcation. Three measurements were acquired at each of the above 
locations to obtain an average across multiple cardiac cycles. 
4.2.3 Preparation for arterial casting 
Following ultrasound measurements, each mouse recuperated for 6-24 hours before 
being prepared for casting of arteries [150, 151]. Briefly, mice were anesthetized with 
urethane at a dose of 1g/kg, and laparotomy was performed to gain access to the abdominal 
aorta, where a 24-gauge catheter was used to make a direct puncture. An incision was 
created in the vena cava to provide an exit point for blood, whereupon a heparinized saline 
(25 U/mL) was injected through the catheter at a pressure of approximately 100-120 
mmHg, the systolic pressure in mice [152, 153]. Pressure was monitored using a 
sphygmomanometer, and a heparinized solution was perfused through the mouse until the 
effluent at the vena cava became clear. Following exsanguination, a 10% solution of 
buffered formaldehyde was perfused through the catheter for 15 minutes at a pressure of 
100 mmHg to fix the blood vessels. Afterwards, 5 mL of Microfil HV 122 Yellow (Flow 
Tech, Carver, MA) was manually perfused. Following the procedure, the upper torso, 
including the head, was removed and stored in 10% buffered formaldehyde for 5 days 
before undergoing decalcification in 10% HCl for 48 hours to remove bone.  
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4.2.4 Micro-Computed Tomography 
Carotid and cerebral artery casts were examined using a high-resolution micro-CT 
imaging system (Quantum GX, Perkin Elmer).  Heads to be scanned were placed prone in 
a specimen tube (diameter 30.7 mm) with the long axis of the head parallel to the tube’s 
long axis. Micro-CT images were collected over a 4-mm thick section extending from the 
nose to the back of the neck, scanning in the transverse plane. Each scan was performed 
with a beam intensity of 80 microamperes, a beam energy of 70 kV, and an isotropic voxel 
resolution of 50 µm. 
4.2.5 Image Processing and Morphological Analysis 
Micro-CT images were used to create 3D models of the cerebral and carotid arteries 
for each specimen. Mimics Materialise 15.0 (Leuven, Belgium), was used to manually 
segment and reconstruct the left and right vasculature, extending from the common carotid 
arteries to the middle cerebral and anterior cerebral arteries. A minimum threshold was 
optimized for each specimen, which produced the largest vessel diameter without creating 
large irregularities on the surface. After a threshold was chosen, a preliminary mesh of the 
vascular network was created, containing arterial segments of the common carotid artery 
(CCA), external carotid artery (ECA), internal carotid artery (ICA), anterior cerebral artery 
(ACA), and middle cerebral artery (MCA). Smoothing algorithms from Vascular Modeling 
Toolkit (VMTK) were applied to remove artifacts created from the reconstruction and re-
meshing [113]. The internal carotid artery is divided into two sections: the extracranial 
internal carotid artery (eICA) and intracranial internal carotid artery (ICA), separated by 
the bifurcation at the ophthalmic artery (OA) branch. After reconstruction, Mimics was 
used to calculate morphometric centerline properties along the length of each arterial 
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segment at a resolution of 0.05 mm. These morphometric values include the maximum 
inscribed internal diameter, perimeter, and cross-sectional area, along the length of each 
arterial segment. When analyzing the morphometric values, regions associated with 
bifurcations were considerably larger than the rest of the artery, thus, to avoid skewing 
results 0.5mm was removed from the end of each arterial segment if that section was part 
of a bifurcation.  The arteries could not be reconstructed in one SS 4-week mouse and one 
SS 24-week mouse.  
4.2.6 Statistical Analysis 
All statistical tests were performed in Graphpad Prism 7. Ultrasound and micro-CT 
data were plotted across age, and data from each group of animals are reported as the mean 
± standard error of the mean. A value of p<0.05 was taken to be significant. The effect of 
genotype was examined using unpaired t-test, and a paired t-test was used to compare 
measurements taken from ultrasound and micro-CT methodologies. A one-way ANOVA 
was performed to determine differences across the various ages.  
4.3 Results 
4.3.1 Enlarged common carotid diameters in 12-week SS mice measured by 
ultrasound and micro-CT 
From ultrasound imaging, luminal diameters were measured in the common carotid 
and the extracranial portion of the internal carotid arteries of mice 4, 12, and 24-weeks of 
age. An average diameter between two points 0.5 mm and 1.5 mm upstream from the 
carotid bifurcation was calculated for the common carotid artery (Fig. 4.1A). At 12-weeks, 
CCA luminal diameters in SS mice during systole were 19.3% and 11.5% larger than those 
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of age-matched AS mice on the left and right sides, respectively (n=4, p<0.05) (Fig 4.1B). 
The CCA remained significantly enlarged during diastole with a 20.1% and 13.7% 
diameter increase occurring in the left and right sides of SS mice. In the extracranial ICA, 
a single point, 0.5 mm distal from the carotid bifurcation was measured, and no significant 
differences were found in this segment at any age (Fig. 4.1A). Table 4.2 contains all the 
measurements from ultrasound imaging of the extracranial carotid arteries. 
 Since there was a limitation in obtaining measurements intracranially with 
ultrasound, we validated that comparable measurements were acquired between ultrasound 
performed on living mice, and the arterial casts measured by micro-CT, on non-living 
animals (Fig. 4,2). Mice 12 weeks old were used for comparisons since that was the age 
when statistically significant differences were observed between SS and AS carotid arteries 
(Fig. 4.3). Values calculated from the reconstructed arteries were only comparable to 
systolic ultrasound measurements as a systolic pressure of at least 100 mmHg was 
maintained throughout the casting process. The maximum inscribed diameter, which is the 
largest circle that can fit within the boundaries of a vessel cross-section (Fig 3A), were 
averaged along the length of the CCA and extracranial ICA. In the CCA this length 
extended 0.5 to 1.5 mm proximal of the carotid bifurcation, and in the extracranial ICA 
this extended 0.4 to 0.6 mm downstream of the bifurcation.  
There were no significant differences between diameters from ultrasound and 
micro-CT methodologies (paired T-test, n=4, p>0.05). Diameters calculated through the 
micro-CT method paralleled the significant differences in the common carotid artery of the 
12-week group for SS vs. AS mice (Fig 3B). Statistically significant differences were 
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Figure 4.1: The common carotid artery (CCA) luminal diameter is enlarged in SS 
mice at 12 weeks of age during the entire cardiac cycle 
(A) The luminal diameter was measured at in the CCA 0.5 and 1.5 mm upstream from the 
carotid bifurcation (labeled O), and in eICA 0.5 mm downstream from the carotid 
bifurcation. (B) The common carotid artery was significantly larger in 12-week SS mice 
during both systole and diastole for the left and right sides. (C) There are no significant 
differences found in the eICA diameters of SS and AS mice. *p < 0.05 SS compared with 
AS by T-test. Error bars are SEM. 
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Table 4.2 Morphological measurements from ultrasound of the extracranial internal 
carotid arteries in mice with sickle trait (AS) and sickle cell anemia (SS). 
 
 
CCA, Common Carotid Artery; eICA, Extracranial Internal Carotid Artery. 
a p < 0.05 compared with AS by t-test. Number in parentheses is standard deviation of the 
measurement. 
Age (Weeks)
Genotype AS SS AS SS AS SS
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Figure 4.2 Casts of blood vessels to acquire morphology of carotid and cerebral 
arteries. 
Top view of perfusion casting process. (A) Microfil, a radio-opaque polymer, was injected 
into the aorta of mice after exsanguination and fixation of the blood vessels under 
pressurized conditions. (B) The head of mouse was decalcified in a 10% HCL solution for 
36 hours to remove bone. (C) The reconstructive software Mimics Materialise was used to 
segment and reconstruct carotid and cerebral arteries. (D,E) Final vascular model with 
individual arterial segments colored. CCA (common carotid artery), eICA (extracranial 
internal carotid artery), ECA (external carotid artery), OA (ophthalmic artery), intracranial 
ICA (internal carotid artery), ACA (anterior cerebral artery), MCA (middle cerebral 




Figure 4.3: Reconstructed models from artery casts recapitulate ultrasound 
measurements from living animals 
Comparison of diameters measured from ultrasound and micro-CT in the 12-week age 
group. (A) micro-CT measurements reveal CCA diameters were larger in SS mice, 
paralleling results from the ultrasound study. No significant differences were found 
between the CCA diameters measured through ultrasound and diameters calculated from 
reconstructed micro-CT images. (B) Diameters calculated from micro-CT were 
significantly larger in SS mice. No significant differences were observed between both 
methodologies, however, diameters calculated through micro-CT had smaller SEM. 
*p<0.05 SS compared with AS by T-test. Paired T-test was performed between ultrasound 
and μCT methodologies for the same genotype. Error bars are SEM. 
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4.3.2 Diameter vs. perimeter and cross-sectional area as reliable metrics.  
Diameter measurements were useful to extract data from the ultrasound, but it 
assumed a perfectly circular geometry, which was not usually the case for these arteries.  
Using the micro-CT analysis of casts, cross-sectional shapes of the artery were evaluated 
for ellipticity, a metric that can be used to determine the roundness of polygons. An 
ellipticity value of 0 is perfectly circular, and values closer to 1 indicate a flatter object. 
The ellipticity in both AS and SS was found to be in the range between 0.4 and 0.6, 
denoting non-circular geometry (Figure 4.4A). Although the diameters (Figure 4.4B) were 
useful for comparing methods of ultrasound vs. micro-CT (Figure 4.3), using micro-CT, 
the cross-sectional perimeter and area of carotid arteries could also be calculated along the 
same length of the artery and were better at capturing the irregular geometry presented by 
the arteries. The perimeter and cross-sectional area were 34.6% and 65% larger, 
respectively, in the left extracranial ICA of SS mice 12 weeks of age (p<0.05, n=3), 
whereas the right extracranial ICA increase was only 8.3% and 18.4%, which was not 
significant (Fig 4.4C&D). There were no significant differences in either perimeter or area 
at 4 or 24 weeks between AS and SS mice. Table 4.3 contains all the measurements from 




Figure 4.4: The extracranial internal carotid artery is enlarged on the left side 
(A) The maximum inscribed circle in a cross-section of the internal carotid artery. (B) The 
maximum inscribed diameter in the extracranial ICA was found to be significantly larger 
in SS mice for both the left and right sides at 12 weeks. (C) The average ellipticity was 
calculated along the extracranial internal carotid artery from 0.4 - 0.6 mm downstream of 
the carotid bifurcation. Ellipticity for both AS and SS mice are between 0.4 and 0.6, 
denoting a more irregular shape (E = 0). Further examination of (D) perimeter and (E) 
cross-sectional area reveals only the left side to have significantly larger morphometric 
values at 12 weeks. *p < 0.05 SS compared with AS by T-test. Error bars are SEM 
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Table 4.3: Morphological measurements from micro-CT analysis of the extracranial 
internal carotid arteries in mice with sickle trait (AS) and sickle cell anemia (SS). 
 
 
eICA, Extracranial Internal Carotid Artery. 
a p < 0.05 compared with AS by T-test.  
Number in parentheses is standard deviation of the measurement. 
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4.3.3 Internal Carotid artery length is similar between SS and AS mice 
Internal carotid artery measurements were captured with micro-CT. When 
examining the entire ICA (extracranial + intracranial) a significant increase occurred as 
mice aged from 4 to 12 weeks. Length in the left ICA increased by 11% (p<0.001) and 8% 
(p<0.01) in AS and SS mice, respectively, with similar increases of 16% (p<0.001) and 
11% (p=0.0525) for the right ICA (Fig 4.5A). There was no significant difference between 
12 and 24 weeks. Comparisons of body weight showed similar trends from 4 to 12 weeks. 
Body weight was 57% (p<0.001) and 53% (p<0.001) greater from 4 to 12 weeks in AS and 
SS mice, respectively. At 24 weeks, weight increased by 3% (p>0.05) in AS and 17% 
(p<0.05) in SS. No significant differences were found between genotypes at the same age. 
These results suggest that radial differences observed in the carotid arteries were not a 
result of differences in the length or weight of the animal.  
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Figure 4.5: Size and axial growth is similar between homozygous and heterozygous 
sickle mice 
(A) Growth axially is quantified based on ICA length (extracranial + intracranial).  ICA 
length increases significantly from 4 to 24 weeks in AS and SS, and no significant 
differences were found between AS and SS mice in any of the age groups. (B) Significant 
increase in body weight occurs from 4 to 12 weeks in AS and SS mice, but no differences 
were found in the same age group between genotypes. SS was compared with AS via T-
test. The same genotype was compared across ages using a one-way ANOVA, *p < 0.05.  
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4.3.4 Narrowing in the left distal intracranial ICA of 12 and 24-week SS mice 
Next, we compared intracranial internal carotid arteries (ICA) reconstructed from 
4, 12 and 24-weeks old mice. Averaged morphometric values were taken from two 
sections: (1) the proximal end, which begins 0.5mm from the beginning of the ICA to the 
midpoint of the vessel; and (2) the distal end, which extends from to the midpoint to 0.5 
before the end of the vessel (Fig 4.6A). At 12-weeks, the proximal diameter, perimeter, 
and cross-sectional area on the left-side of SS mice were enlarged compared to AS controls, 
increased by 15% (0.048+/-0.02), 16% (1.322 mm +/- 0.025), and 34% (0.139 mm2 +/- 
0.005), respectively (Fig 4.6C&D). This difference continued distally, where a 16% 
(p<0.05) and 32% (p<0.05) increase was measured in perimeter and area. At 24 weeks, the 
left proximal section was also enlarged for SS mice, with a 17% increase in perimeter and 
40% increase in area as compared to AS. Unlike, their younger 12-week counterparts, 
morphometric values were not significantly different at distal ICA. 
These changes from the proximal to distal ICA could be visualized by plotting the 
mean area for each genotype along the length (Fig 4.7.1). At 4 weeks, SS and AS mice had 
similar areas along the length. However, in the 12- and 24-week age groups SS mice had 
significantly larger cross-sections at the proximal ICA, which narrowed, leading to a loss 
of differences once reaching the opposite end of the artery. To quantify this narrowing in 
the ICA, area was normalized to the area at the proximal start of the artery for each mouse 
(Fig 4.7.2). Using this method, variability between specimens can be accounted, and 
differences previously unseen begin to emerge. The normalized area in 12-week SS mice 
was as much as 36% lower compared to AS mice. At 24 weeks these differences were even 
larger; at certain points along the ICA the percent change in area for SS mice reached as 
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low as  -62 and -56% in the left and right sides, respectively. Both the left and right 
intracranial internal carotid arteries narrowed in 12 and 24-week-old SS mice. Table 4.4 







Figure 4.6: Radial growth of the distal intracranial ICA in SS mice is slowed 
between 12 and 24 weeks of age 
(A) The intracranial ICA was divided into two regions: proximal, extending 0.5 from the 
origin to the midpoint and distal which continues from the midpoint to 0.5 mm before the 
ICA bifurcation (labeled end). (B) Diameter, (C) perimeter, and (D) cross-sectional area is 
compared between AS and SS mice at the proximal and distal segments of the intracranial 
ICA. The left ICA is significantly larger by all morphometric values at 12 weeks at the 
proximal and distal ends. The proximal ICA is also enlarged in 24-week SS mice but 
narrows at distal portion losing significance at that end of the ICA. *p<0.05 SS compared 
with AS by T-test. Error bars are SEM. 
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Figure 4.7.1: Distal Intracranial Internal Carotid Artery Narrows in 12 and 24-
week SS mice. 
Mean values for bulk area and percent change in area are plotted along the length of the 
intracranial ICA. (A) The left proximal ICA is enlarged in 12- and 24-week SS mice, but 
differences are lost upon moving towards the distal section of the artery. *p<0.05 SS 




Figure 4.7.2: Distal Intracranial Internal Carotid Artery Narrows in 12 and 24-
week SS mice. 
Area was normalized to the starting point of artery to account for variability between 
subjects. The ICA narrows significantly from the proximal to distal end of the artery in 24-
week SS mice as compared to age-matched controls. *p<0.05 SS compared with AS by T-
test. Error bars are SEM. 
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Table 4.4: Morphological measurements from micro-CT analysis of the intracranial 
internal carotid arteries in mice with sickle trait (AS) and sickle cell anemia (SS). 
 
 
ICA, Intracranial Internal Carotid Artery. 
a p < 0.05 compared with AS by T-test. 
Number in parentheses is standard deviation of the measurement. 
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4.3.5 Portions of the anterior cerebral arteries are significantly narrower in SS mice 
 Two tributaries branch from the ICA, the middle cerebral (MCA) and anterior 
cerebral arteries (ACA) and were examined using the same methods from the reconstructed 
micro-CT models. In the ACA, morphometric values were analyzed along a length of 0.5 
to 2.5 mm, whereas the longer MCA calculated values from 0.5 to 4.5 mm of the origin. 
When examining the area, neither the ACA nor MCA differed significantly in size between 
AS and SS mice (Fig 4.8.1 & Fig 4.8.2). It should be noted that at 24 weeks, the right ACA 
in SS mice had significantly smaller diameters (*p<0.05). To investigate the geometry 
further, normalized area was plotted vs. length for the ACA and MCA (Fig 4.9 and Fig 
4.10). Using this approach, the left ACA was found to be enlarged in 4-week SS mice. 
However, at 12 and 24 weeks the ACA of SS mice were significantly smaller in both the 
left and right sides, narrowing by up to 60% in some segments. The normalized MCA area 
between SS and AS mice changed throughout aging. SS mice had enlarged MCAs at 4-
weeks, but by 24 weeks the cross-sectional area was narrowed compared to AS controls.  




Figure 4.8.1: The morphology in the anterior cerebral arteries are similar between 
SS and AS mice. 
The ACA does not significantly differ in size between AS and SS mice. At 24 weeks 
however, the right ACA in SS mice does tend to be smaller with diameters being 
significantly smaller. *p < 0.05 SS compared with AS by T-test. Error bars are SEM.  
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 Figure 4.9.2: The morphology in the middle cerebral arteries are similar between 
SS and AS mice. 
Morphology in the MCA is not affected by genotype as the diameter, perimeter, and cross-
sectional area are not significantly different, regardless of age or side. *p < 0.05 SS 





Figure 4.10: Portions of the anterior cerebral arteries are significantly narrower in 
SS mice. 
Mean values of percent change in area are plotted along the length of the ACA. The left 
ACA is enlarged in 4-week SS mice. At 12 and 24 weeks the ACA of SS mice becomes 
narrowed at various portions of the ACA, in both the left and right sides. *p < 0.05 SS 
compared with AS by T-test. Error bars are SEM.  
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Figure 4.10: Portions of the anterior cerebral arteries are significantly narrower in 
SS mice. 
Mean values of percent change in area are plotted along the length of the MCA. The right 
MCA is enlarged in 4-week SS mice, but this difference disappears as the mice age. The 
proximal section of the left MCA in 24-week SS mice is significantly narrower. *p < 0.05 





Table 4.5: Morphological measurements from micro-CT analysis of the cerebral 
arteries in mice with sickle trait (AS) and sickle cell anemia (SS). 
 
 
MCA, Middle Cerebral Artery; ACA, Anterior Cerebral Artery. Standard error of the mean 
is shown in parentheses 
a p < 0.05 compared with AS by T-test. 




Here we performed a cross-sectional study using a combination of ultrasound and 
micro-CT imaging to quantify and characterize morphology in the carotid and cerebral 
arteries at different ages of mice to examine differences between mice with sickle cell 
anemia (SS) or littermate heterozygous (AS) controls. Morphometric values calculated 
from micro-CT imaging of extracranial carotid artery casts paralleled measurements from 
the live mouse during systole. This suggest that morphometric values calculated in the 
cerebral arteries are within physiological norms. Significant differences found only 
through micro-CT in the extracranial ICA was a result of the greater resolution at which 
points can be measured. Through ultrasonography only a few distinct points can be 
measured in a vessel; however, using the reconstructed arteries multiple points can be 
analyzed along the length and averaged together. This reduces the overall error in the 
measurement. Additionally, the diameter measured from ultrasound is of a cross-section, 
and did not consider the irregular shape of the vessel. Measurements calculated through 
the reconstructed artery can provide area and perimeter, thereby quantifying the true shape 
of the vessel. 
 The greatest differences when examining the morphometric values were observed 
between AS and SS mice in the 12-week age group. The left common carotid artery 
diameter was larger in SS mice as measured through both ultrasound and micro-CT 
measurements. This result agrees with findings obtained by Cahill et. al, who compared 
the homozygous sickle Townes mice to C57BL/6J wild-type counterparts in 10 to 13-
week-old mice [138] and also found SS mice to have significantly larger common carotid 
arteries measured via ultrasound. Extending downstream, the entire intracranial ICA was 
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significantly larger on the left side in SS mice 12 weeks of age. At 24 weeks however, only 
the proximal portion of the ICA was found to have significantly larger cross-sectional 
perimeters and areas. These results parallel findings in humans, as direct measurements via 
magnetic resonance angiography have shown luminal area to be larger in the ICA, ACA, 
and MCA of patients with SCD as compared to age matched controls [154]. Additionally, 
although there was a significant growth from 4 to 12 weeks; axially, ICA length was similar 
between SS and AS mice, and overall body weight showed no difference, matching 
previous studies [155]. Therefore, the radial differences observed in SS mice, is not due to 
differences in animal size but is a result of the animal genotype.  
The larger luminal areas measured in SS mice may be an indication of vasodilation 
in order to generate higher cerebral blood flows. Reduced oxygen availability in SCA is 
compensated by elevated cerebral blood flow (CBF) to increase the rate of oxygen delivery 
[156, 157]. This is supported by a reduced cerebral vasculature reserve in humans and mice 
with sickle cell disease [37, 138, 158]. When subjected to hypoxic conditions the blood 
vessels in subjects affected by SCA are unable to dilate to the same extend as non-sickle 
cell controls, Therefore the change in cerebral blood flow is reduce in those with SCA. The 
enlarged lumens measured in the CCA and ICA of our SS mice could be attributed to this 
mechanism, and direct measurements of the luminal area in the cerebral arteries have also 
shown the ICA to be enlarged in humans with sickle cell disease [154]. It is important to 
note that both anesthetics used in this study, isoflurane for the ultrasound procedure and 
urethane for the perfusion casting of the arteries, are both vasodilators [159, 160]. 
Therefore, the morphological differences between AS and SS mice maybe even larger in 
the proximal internal carotid artery under normal physiological conditions.  
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In the distal intracranial ICA, however, a distinct narrowing was observed which 
led to a loss of the statistically significant difference between SS and AS mice at 24-weeks 
of age. This narrowing was quantified by normalizing the area to the most proximal point 
of the artery and plotting the percent change in area against length. Through this method 
we can see that the ICA was significantly narrower at certain portions of the distal ICA, in 
right and left sides of 12 and 24-week week old mice. Using this method again, significant 
narrowing occurred in the ACA of SS mice (Fig 9), despite seeing no significant 
differences in the morphometric properties, with the exception of the ACA diameter being 
smaller in 24-week SS mice.  This narrowing in luminal area in SS mice suggests a 
potential for hemodynamic changes as well. Elevated blood velocities are known to occur 
in the presence of stenoses cerebral arteries, and high cerebral blood velocities have been 
associated with stroke risk in with sickle cell anemia[4, 28, 50]. Therefore, the narrowing 
observed in these mice with SCA could also produce elevated blood velocities 
Reduction in normalized area in the ICA and ACA of SS mice could be associated 
with vascular remodeling. Cerebral angiograms of individuals who have suffered from 
strokes have shown that the occurrence of stenotic lesions in the cerebral arteries [4, 5]. 
Characterization of these stroke lesions have shown remarkable vascular remodeling 
characterized by intimal hyperplasia [5]. Additionally, increased cellular adhesion of 
leukocytes and erythrocytes in sickle cell anemia may also contribute to the observed 
luminal narrowing [29, 103, 161]. While this is mostly observed in the microvasculature 
others have shown that monocytes and red bloods cells can adhere in the large arteries as 
well [28, 103]. Determining the pathological mechanisms for this luminal narrowing may 
help in developing therapeutics for preventing strokes. 
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Differences between AS and SS were mostly observed in the 12-week age group. 
Age is known to be a strong factor of stroke risk in sickle cell anemia, with the highest risk 
of ischemic stroke occurring between the ages of two and five in humans [33]. Ages of 
mice do not correlate linearly to human age, as maturation in the first month of life occurs 
150 times faster and later months have a third of the previous maturation rate [162]. 
Approximations can be made to compare mouse lifespans to clinical pathologies in humans 
with sickle cell  at certain ages. At four weeks, mice are in early adolescence 
(approximating humans of 10-12 years old), while at 12 weeks mice approximate humans 
in their early 20s. At 24 weeks, the mice approximate humans in their early 30s. Individuals 
with SCA in their 20s have an elevated risk of hemorrhagic stroke [52]; the bulk 
morphometric differences observed in 12-week mice may be related to this type of stroke. 
Though no aneurysms were found in the mice themselves, uncontrolled expansion of the 
artery can lead to hemorrhagic stroke. At 24 weeks of age, mice approximate the age of 
humans in their 30s, and this is the age at which humans with SCA have an elevated risk 
of ischemic stroke [52]. The narrowing observed in the cerebral arteries of mice with SCA 
could potentially cause a stroke as blockages in these narrowed sections of the artery may 
prevent an adequate supply of blood and oxygen. 
The left common carotid and internal carotid artery lumens were larger in SS mice 
compared to AS mice. The cause for these differences is not fully known. It has been 
previously reported that the hippocampus, thalamus, and visual cortex on the left side of 
the brain in C57BL/6J mice, one of the background strains for the Townes mice, are 
enlarged [163]. These regions are supplied by several arteries that branch from the ICA 
and may have higher oxygen demands than their counterparts on the right. This could 
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potentially be magnified in a mouse with sickle cell anemia, leading to the larger artery 
size that was observed. 
This study has important limitations. Some age groups had as few as three mice per 
genotype, which limits our ability to generalize these results. We can therefore only draw 
conclusions regarding differences in vessel morphology across genotypes but not within 
the genotypes themselves. The Townes sickle transgenic mouse model are a clonal strain 
therefore there should be little variation within a single genotype. The precision of the 
measurements in the cerebral arteries are limited by variations in the perfusion casting and 
image resolution. To maximize reproducibility of our results we monitored the pressures 
used during the casting produce and  perfused under physiological pressures of 100–120 
mmHg [152, 153]. Additionally, during reconstruction of the cerebrovascular arteries, the 
same protocol was applied to each specimen to reduce inconsistency. Individuals were 
blinded during reconstruction, and the finalization of the model was performed by the same 
individual. 
In conclusion, this cross-sectional study characterizes morphological 
characteristics in the carotid and cerebral arteries of SS and AS mice from ages 4 – 24 
weeks. Casting of the arteries corresponds to in vivo measurements and provides 
information in regions of the vasculature that cannot be easily imaged with other modalities 
in mice. Morphological differences between genotypes were found to occur in 12- and 24-
week mice, coinciding with the different types of strokes that are most prevalent in humans 
with SCA.  This suggests that SCA affects the vascular morphology, continually changing 
the cerebrovascular system through the entire lifespan of the subject, whether mouse or 
human. Through quantification of the morphometric values it may be possible to predict 
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the type and likelihood of stroke in an individual with SCA. Future work is needed to 






CHAPTER 5  COMPUTATIONAL FLUIDIC DYNAMICS 
SIMULATION OF HEMODYNAMIC ABNORMALITIES IN 
THE CEREBROVASCULATURE OF MICE WITH SICKLE 
CELL ANEMIA 
5.1 Introduction 
Sickle cell anemia (SCA) is one of the most prevalent blood disorders afflicting 
millions globally. Amongst the morbidities associated with SCA, ischemic strokes occur 
at an abnormally high rate in children. Individuals with SCA have more than an 11% 
chance of developing overt strokes before the age of 20[3, 33]. Currently, the only method 
to determine stroke risk is through transcranial doppler (TCD), which is used to measure 
elevated blood velocities in cerebral arteries. When blood velocities in either the 
intracranial internal carotid (ICA), middle cerebral (MCA), and/or anterior cerebral arteries 
(ACA) exceed a time-average maximum-mean velocity (TAMMV) of 200 cm/s, an 
individual with SCA is classified as high stroke risk [1, 40, 41]. Several studies have shown 
the presence of large stenoses, via angiograms, in the cerebral arteries of individuals with 
elevated blood velocities [28, 43]. However elevated cerebral blood velocities can still 
occur in the absence of stenoses [51]. Therefore, the pathophysiology responsible for 
elevated blood flow in those with SCA at risk for stroke is not fully understood. 
Mouse models offer a powerful tool for investigating the effect of genetic diseases 
on the cerebrovasculature. Atherosclerosis [3,4], stroke [5,6,7], aneurysms [8,9], are 
amongst several cerebrovascular pathologies being investigated in mice. The humanized 
Townes sickle cell transgenic mouse model is commonly used in the area of sickle cell 
research. Null for murine α,  and β-globin genes and it contains knock-in genes that produce 
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human hemoglobin genes (α, β, and γ), including the β-globin S mutation [135]. 
Specifically, the Townes sickle mouse has been beneficial for investigating pulmonary and 
hematological pathophysiology, but a few studies target cerebrovascular research [135-
137]. Characterization of the hemodynamics in the carotid and cerebral arteries is 
incomplete and it is unknown if the abnormal cerebral blood velocities observed in humans 
with SCA carry into the murine model. Therefore, characterizing the cerebral vasculature 
of the Townes mouse model is crucial to investigating sickle mediate strokes, and testing 
future pharmacological therapeutics.  
High-frequency ultrasonography has been used to measure velocities in the carotid 
arteries of mice, however, obtaining accurate measurements in the cerebral arteries, has 
proven to be more difficult. This is due to a combination of the smaller vessels that 
comprise these arteries in addition to the shielding created by the skull. To overcome this 
deterrent, computational fluid dynamics (CFD) can be used to approximate cerebral blood 
velocities. CFD has often been used as a tool in the cardiovascular system to determine the 
hemodynamics in regions where traditional tools are ineffective, and thus can be used to 
investigate the biological processes that are occurring. Wall shear stress (WSS) and 
oscillatory shear index (OSI) [7, 8] are two hemodynamic parameters that play an 
important role in the pathogenesis of atherosclerosis. WSS acting on the endothelium 
surface is an important determinant of endothelial function and phenotype [8]. 
Additionally, Cheng et al. assessed the effect of in vivo alterations of shear stress on the 
development of atherosclerosis in apoE-deficient mouse and concluded that low WSS and 
OSI are both essential conditions in plaque formation [13].  
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The goal of this study is to examine the cerebrovascular hemodynamics in 
homozygous sickle cell (SS) mice at varying ages. Age is known to be a strong factor of 
stroke risk in sickle cell anemia, with the highest risk of ischemic stroke occurring between 
the ages of 2 and 8 [33], and decreases until the third decade of life whereupon risk begins 
risk again [52]. Therefore, it is important to determine the age-related morphometric 
changes that are occurring in the cerebral vasculature of the Townes mouse model, and 
how these changes relate to stroke risk. 
To investigate cerebral blood flow in the Townes sickle cell mouse model, we use 
a combination of ultrasonography followed by casting in the carotid and cerebral arteries 
[150] to obtain boundary conditions for a CFD model based on the finite element method. 
The model was validated by comparing simulated extracranial ICA values to ultrasound 
measurements. Subject-specific blood flow was simulated in the ICA, MCA, and ACA of 
mice with sickle cell anemia in order to characterize the hemodynamics and approximate 
the velocity. Twelve-week SS mice were found to have higher TAMMV in the cerebral 
arteries as compared to heterozygous (AS) littermate controls. Additional simulations 
using the same inlet boundary condition for all samples, revealed significant hemodynamic 
differences between SS and AS mice were due to morphological differences. Together this 
work characterizes age-dependent hemodynamic changes in the carotid and cerebral 




5.2.1 High Frequency Ultrasonography 
 A VEVO 2100 Doppler system (VisualSonics, Toronto, ON, Canada) with a 22-55 
Mhz transducer (MS550D, wavelength ~50 µm – 2 mm), was used to measure the blood 
velocities in the common carotid (CCA) and extracranial internal carotid arteries (eICA). 
Mice were anesthetized with 5% isoflurane and maintained at 1% on a horizontal platform 
in the supine position. Afterwards, hair was then removed from the neck and pectoralis, 
before ultrasound gel (Aquasonic, Parker Laboratories) was applied to improve signal 
acquisition. The ultrasound beam applied perpendicular to the arteries. The carotid 
bifurcation, which consist of the distal CCA, eICA, and external carotid artery (ECA), was 
identified in B-mode based on depth from the surface of the skin, direction of flow, and 
spatial orientation. In M-mode the velocity spectrum was recorded in the CCA (~1mm 
upstream of the carotid bifurcation), and in the extracranial ICA (~0.5 mm downstream of 
the carotid bifurcation) (Figure 5.1). The sample area was adjusted to encompass the entire 
lumen and have the smallest intercept angle to the direction of flow. This process was 
performed in the left and right sides and optimized to display the highest velocity and 
sharpest waveform possible for each artery before being recorded.  
Mean waveforms from the velocity spectrum across 5-8 cardiac cycles were 
digitized using GetData and imported into a custom Matlab script (Appendix 2) to extract 
hemodynamic values. Briefly, velocities profiles were interpolated using a polynomial 
function to obtain a constant time step of 0.05 ms.  Individual waveforms corresponding to 
one cardiac cycle were then identified and overlaid on top of each other, to calculate a time-
average waveform (Figure 5.1B).  
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Figure 5.1: Quantification of time-averaged hemodynamic parameters. 
(A) The blood velocity was obtained in the CCA ~1mm upstream of the common carotid 
bifurcation (labeled O), and in the eICA ~0.5mm downstream of the carotid bifurcation. 
The mean value of the velocity spectrum (purple line) was used for all analyses. The green 
line is heart rate. Ultrasound image was enlarged for clarity (B) The time-averaged 
hemodynamic parameters were obtained by identifying individual component waves and 
overlaying them on top of each other (grey lines). The individual waves were averaged to 
generate a time-averaged velocity profile (black line). Peak systolic velocity (PSV) is the 
highest peak of the average waveform, and the end diastolic velocity (EDV) is the velocity 
at the end of the cardiac cycle.   
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5.2.2 Perfusion Casting 
Following ultrasound measurements, each mouse recuperated for 6-24 hours before 
being prepared for micro-CT [150]. Briefly, mice were anesthetized with urethane at a dose 
of 1g/kg, and laparotomy was performed to gain access to the abdominal aorta, where a 
24-gauge catheter was used to make a direct puncture and held via sutures. An incision was 
created in the vena cava to provide an exit point for blood, whereupon a heparinized saline 
solution (25 U/mL) was injected through the catheter at a pressure of approximately 120 
mmHg, the systolic pressure in mice [152, 153]. Pressure was monitored using a 
sphygmomanometer, and the heparinized solution was perfused through the mouse until 
the effluent at the vena cava became clear. Following exsanguination, a 10% solution of 
buffered formaldehyde was perfused through the catheter for 15 minutes at a pressure of 
120 mmHg to fix the blood vessels. Afterwards, 5 mL of Microfil HV 122 Yellow (Flow 
Tech, Carver, MA) was manually perfused. Following the procedure, the upper torso of the 
mouse, including the head, was detached and stored in 10% buffered formaldehyde for 5 
days before undergoing decalcification in 10% HCl for 48 hours. After decalcification, 
each mouse was again stored in 10% buffered formaldehyde, until undergoing micro-CT.  
5.2.3 Micro-Computed Tomography 
The carotid and cerebral arteries were examined using a high-resolution micro-CT 
imaging system (Quantum GX, Perkin Elmer). During the day of the examination, mouse 
heads were placed in a specimen tube (diameter 30.7 mm) in the prone position with the 
long axis of the head parallel to the tube’s long axis. Examination of the brain was 
performed by scanning in the transverse plane with micro-CT images of the head taken 
over a 4-mm thick section extending from the nose to the back of the neck. All scans were 
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performed with a beam intensity of 80 microamperes, a beam energy of 70 kV, and an 
isotropic voxel resolution of 50 um. 
5.2.4 Segmentation and Reconstruction of Carotid and Cerebral Arteries 
Micro-computed tomography images were used to create 3D models of the carotid 
arteries for each specimen. Mimics Materialise 15.0 (Leuven, Belgium), was used to 
manually segment and reconstruct the left and right arteries, extending from the common 
carotid arteries to the middle cerebral and anterior cerebral arteries (Figure 5.2). A 
minimum threshold was optimized for each specimen, which produced the largest vessel 
diameter without creating large irregularities on the surface. After a threshold was chosen, 
a preliminary mesh of the vascular network was created, containing arterial segments of 
the CCA, ECA, ICA, ACA, and MCA. The internal carotid artery is divided into two 
sections the extracranial internal carotid artery (eICA) and intracranial internal carotid 
artery (ICA). The intracranial ICA was defined as the section downstream of the 
ophthalmic artery branch. In order to remove any artifacts created from the reconstructive 
process, re-meshing and smoothing algorithms from Vascular Modeling Toolkit (VMTK) 
were applied to the model. After reconstruction, Mimics was used to calculate diameter 
along the length of each arterial segment. 
The reconstructed arteries were separated into two sections: (1) the common carotid 
bifurcation (CCA, eICA, and ECA), and (2) the intracranial internal carotid bifurcation 
(ICA, MCA, ACA) (Figure 3). Flow extensions with a length equal to 4 times the 
corresponding inlet or outlet diameter was added to the model in order to ensure the fluid 
flow entering and exiting the system was undisturbed and parabolic. The final mesh used 





Figure 5.2: Carotid and Cerebral Artery Model of a Sickle Transgenic Mouse. 
Reconstruction of the carotid and cerebral arteries segmented from micro-computed 
tomography images of perfusion casted vessels. CCA (common carotid artery), ECA 
(external carotid artery), eICA (extracranial internal carotid artery), OA (ophthalmic 
artery), ICA (intracranial internal carotid artery), MCA (middle cerebral artery), ACA 




Figure 5.3: Partitioning of carotid and cerebral arteries for computational fluid 
dynamic simulations. 
The reconstructed arteries were divided into two segments for finite element analysis. (A) 
The carotid artery system containing the CCA, eICA, and ECA was primarily used to 
validate the computational model. (B) The cerebral artery system contains ICA, MCA and 
ACA. Flow extensions were added to ensure the fluid flow entering and exiting the system 
was undisturbed.  
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5.2.5 Computational Fluid Dynamic Model 
The finite element method was used to simulate blood flow in both arterial systems. 
Meshes were imported into LifeV, an open source Object Oriented C++ Finite Element 
solver developed as a joint initiative of Department of Mathematics at EPFL, Lausanne 
CH, Department of Mathematics at Politecnico di Milano, Milan, IT and the Department 
of Mathematics and Computer Science at Emory University, Atlanta (GA) USA [16]. 
The incompressible continuity equation (Eq. 5.1) and the Navier-Stokes equations 
for momentum (Eq 5.2) functioned as the governing equations and were applied to the 
region of the model delimited by the inlet, outlets, and walls of the vascular tree.  




= ∇𝑃 +  𝜇∇2𝒗(Equation 5.2) 
Vessel walls were assumed to be rigid, and the no-slip condition was applied 
causing the velocity at the wall to be zero. Additionally, hydrostatic effects were assumed 
to be negligible and fluid was considered as a Newtonian and incompressible. The fluid 
was assumed to have the same properties of mouse blood with a density of 1057 kg/m3 and 
viscosity of 4.879 cP [44, 88, 89]. 
At the inlets, a time-averaged velocity waveform calculated from the ultrasound 
measurements was applied for each individual animal. In the common carotid model, the 
exact waveform was applied to the CCA inlet. In the internal carotid artery, Murray’s Law 
(Eq. 5.3) was used to approximate a flow split from the upstream eICA to the downstream 








Where D is vessel diameter and (?̇?) is the volumetric flow rate through the vessel.  
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Simulations were performed in 4 and 12-week mice for both the left and right sides 
at a time step of 0.0005s across three cardiac cycles. Since each specimen had their own 
unique velocity profile, the total time varied.  
Prior to the actual simulation the velocity entering the system was slowly ramped-
up for several fictions time steps prior, until it matched the actual velocity waveform. This 
was done to avoid potential instabilities created from mismatches in the inlet boundary and 
initial conditions.  
At the outlets a three-element Windkessel model consisting of a resistor in series 
with both a capacitor and resistor in parallel was utilized (Fig. 5.4). This was done to 
produce a pressure gradient and relate the outgoing artery velocity to the pressure of the 
outlet. The first resistor (R1) represents the respective resistance of the outgoing artery; and 
the capacitor (C) and the second resistor (R2) signifies the total compliance and resistance 
of all peripheral vessels to the outgoing artery. Outflow pressure is calculated based on 
outflow velocity and predetermined resistances and compliances of the vessel.  Variables 
for the listed equations are defined as follows: density (ρ), inviscid wave speed or pulse 

























 (Equation 5.6) 
 
 
Figure 5.4: Three Element Windkessel Model 
Schematic of a three element Windkessel model and the defining equation for the 
individual elements. The Windkessel is used to relate pressure and flowrate in the 




 Peripheral resistance (R2) can be approximated from the geometry of the outlet 
vessel (Eq 5.4), therefore the resistance at each outlet (ECA, eICA, MCA, and ACA) was 
estimated from calculated values of diameter and length. Calculating R1 and C are more 
difficult as both pulse wave velocity (Eq 5.5) and change in vessel volume (Eq 5.6) could 
not be measured directly. Therefore, scaling laws were used to approximate these variables. 
While the classical impedance of a vessel is defined as the change in volume over the 
changed in pressure from systole to diastole, impedance can also be estimated from the 





 (Equation 5.7) 
Where ρ is density of blood, and V is the volume of the vessel, which can be approximated 
by assuming a cylindrical shape. Therefore, both R1 and C can be estimated through scaling 
of pulse wave velocity. In work published by Aslanidou et. al., they were able to derive an 
equation (Eq 5.8) relating pulse wave velocity to lumen diameter in C57BlL/6 mice one of 







 To validate the model and ensure that the values for resistance were correct the 
common carotid artery model was used. Simulated values in the extracranial ICA were 
compared to the actual ultrasound measurements. The simulations were ran in parallel 
among 8 processors, which were afterwards compiled together using a script developed in 
C++. Visualization and analysis of the data from the simulation was completed in 
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Paraview. Only the third and final cardiac cycle was analyzed to avoid potential 
instabilities that might have occurred in earlier time steps. The TAMMV was calculated in 
each artery by taking a cross-sectional slice in each arterial segment at location at which 
velocity was highest. 
.  
5.2.6 Statistical Analysis 
 All statistical tests were performed in Graphpad Prism 7. Data was plotted across 
age, and data from each group of animals are reported as the mean ± standard mean error. 
A value of p < 0.05 was taken to be significant. The effect of genotype was examined using 
unpaired T-test. [4 weeks nAS = 6, nSS = 3), 12 weeks (nAS = 7, nSS = 4), 24 weeks (nAS = 
4, nSS = 3)]. 
5.3 Results 
5.3.1 Time-average maximum-mean velocities are similar in the carotid arteries of 
AS and SS mice 
Doppler ultrasound revealed TAMMV in the common carotid artery was similar 
for AS and SS mice at all age groups (n = 3-7, p > 0.05) (Fig 5.5A). This pattern extended 
downstream into the extracranial ICA where no significant differences were found between 
the two genotypes (n = 3-7, p > 0.05). At 12 weeks however, AS mice had slightly elevated 
velocities compared to their SS counterparts (23.17 ± 2.12 cm/s vs 15.78 ± 3.69 cm/s in 




Figure 5.5: Velocities in the carotid arteries are similar between SS and AS mice 
The mean of the velocity spectrum from 5-8 cardiac cycles in the CCA and eICA were 
averaged together to obtain a time-averaged mean waveform for each mouse, where upon 
the time-average maximum-mean velocity (TAMMV) was calculated. The TAMMV was 
not significantly different between in AS and SS mice at any age in either the common 
carotid (A) or extracranial internal carotid artery (B). *p < 0.05 SS compared with AS by 
T-test. Error bars are SEM. 
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5.3.2 Computational fluid dynamic simulations can recapitulate in vivo ultrasound 
measurements in the carotid arteries 
 The carotid artery system was used to validate the computational model. Subject-
specific simulations were performed such that the CCA waveform measured in a mouse 
was paired and used as the inlet velocity for that specific same mouse’s geometry. Blood 
flow were simulated in 5 12-week AS mice, using the conditions previously described. 
Velocities were analyzed at cross-sections taken from the CCA and eICA. As expected, the 
inlet CCA velocity prescribed to the system perfectly matched the corresponding 
ultrasound measurements from which it was derived (Fig 5.6). Velocities in the eICA 
varied from the exact ultrasound measurement but the TAMMV did not differ by more 
than 30% in any of the samples. A comparison between simulated and ultrasound TAMMV 




Figure 5.6: Simulated model flow velocity compared to in vivo ultrasound 
measurements. 
(A) Blood flow was simulated in the carotid artery model. Cross-sections (dotted line) were 
taken from the CCA and eICA to determine the mean velocity profiles. (B) Representative 
figures of the mean velocity profiles in the CCA and eICA calculated from the simulation. 
The mean velocity in the CCA exactly matches the ultrasound measurement from which it 
was derived. There are some differences between the simulated eICA velocity and the 
ultrasound measurement.  
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5.3.3  Time-average maximum-mean velocities in subject-specific simulations are 
slightly elevated in SS Mice 
 Subject-specific CFD were performed using the cerebral artery model in order to 
estimate the velocities in the key arteries associated with stroke. Examining the velocity 
streamlines during systole, reveals cerebral velocities to be elevated in SS mice at 12 -
weeks of age (Fig. 5.7). In order to quantify the differences that were visually observed, a 
technique was applied similarity to how TAMMV is reported clinically. While performing 
TCD on individuals with SCA, multiple measurements are made in the ACA, MCA, and 
ICA in both the left and right sides; and only the highest velocity is reported [36]. 
Therefore, using this method as a basis, each artery was examined separately for each 
animal, such that TAMMV was only calculated at the location in vessel where it was the 
highest. For analysis in the whole brain, only the highest TAMMV amongst all the cerebral 
arteries in an animal was used (Fig. 5.8A). Simulations revealed TAMMV in 4W mice 
were similar for AS (58.18 ± 7.14 cm/s) and SS mice (84.14 ± 36.23 cm/s) (p > 0.05). At 
12 weeks, a trend towards elevated TAMMV was observed in SS mice (139.01 ± 59.15 
cm/s) as compared to AS mice (54.13 ± 59 cm/s) (p < 0.1). Standard error was greater in 
the SS mice, indicating greater variance. When examining all the cerebral arteries 
separately, elevated TAMMV in the 12-week age group to be localized to the right ACA 
(Fig 5.8B). Two mice in this group had particularly high velocities (298.87 cm/s and 158.2 








Figure 5.7: Velocities in the cerebral arteries are elevated in 12 SS mice. 
Representative images of the velocity streamlines in the right ICA are shown for SS and 
AS mice at 4, and 12 of age. Regions of high velocity (arrows) were found to occur in 12 
and 24-week mice. 
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Figure 5.8: Time-averaged maximum-mean velocities from subject-specific 
simulations are slightly elevated in the right ACA of SS mice. 
The highest TAMMV was calculated amongst all cerebral arteries (A) as well in each 
arterial segment: ACA (B), MCA (C), and ICA (D). A trend towards elevated TAMMV is 
observed in SS mice, specifically due to high velocities measured in the right anterior 
cerebral artery. *p < 0.05 SS compared with AS by T-test. Error bars are SEM. 
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5.3.4 Geometries from 12-week sickle cell mice generate significantly elevated 
cerebral velocities with a fixed velocity waveform. 
 Simulations were repeated for the 12-week age group to determine if the elevated 
velocities observed in some of the SS mice were due to morphological differences created 
by SCA. The same inlet velocity profile was used for all subjects to remove variability 
produced from using subject-specific velocities. Using these new boundary conditions, SS 
mice were found to have a significantly higher TAMMV (p < 0.05), when examined across 
all cerebral arteries, and equated to a 143.9% increase from AS controls (Fig 5.9).  
Differences were again mostly found in the right ACA (p < 0.1), indicating that the 
geometry may be a probable cause for the elevated velocities. When the normalized cross-
sectional area in the right ACA was examined, SS mice were found to have significant 
narrowing, up to 60% in some segments. 
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Figure 5.9: Geometries from 12-week sickle cell mice produce significantly elevated 
cerebral velocities when using the same inlet velocity. 
Simulations were repeated in the 12-week age group utilizing the same inlet velocity 
boundary condition for all animals. Across the all cerebral arteries TAMMV was 
significantly in SS mice, and with differences due to elevated velocities in ACA. *p < 0.05 





Here we have developed a subject specific computational model for approximating 
the velocities in the cerebral arteries of a mouse with sickle cell disease. Using a 
combination of ultrasonography and plastination techniques we were able to quantify and 
characterize the hemodynamics in the cerebral arteries of sickle transgenic mice. This was 
validated by performing simulations in the carotid arteries. Simulated velocities in the 
extracranial carotid arteries matched well to in vivo ultrasound measurements.   
 Blood flow in the carotid arteries are can be higher in individuals with SCD 
regardless of stroke risk [169-171], and has been associated with increased cardiac output 
and/or decreased cerebrovascular reserve [172].  Sun et. al confirmed the CCA velocity in 
six-month (24 week) SS mice was elevated but only in comparison to AA counterparts 
[142]. Between AS and SS mice no differences were found in the peak systolic velocities 
or mean velocities for either 4 or 24-week mice, matching results from our study. This 
work demonstrated that in the cerebral arteries, velocities were elevated in mice with SCA. 
Though no significant differences were found in the subject-specific simulations a strong 
trend of elevated TAMMV was observed in 12-week SS mice. It is important to note that 
only ~10% of individuals with SCA suffer from ischemic strokes, and while this number 
is high compared to age-matched controls, it does represent a certain sub-population. 
TAMMV had a larger variance in the SS group, and these differences may be attributed to 
different sub-populations in sickle cell anemia. Performing additional studies on a larger 
sample size, may assist in identifying this population with high TAMMV in SCA.  
Perturbation of the simulations by applying equivalent inlet velocity conditions has 
shown that geometries of mice with SCA produce significantly elevated TAMMV. Our 
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results suggest luminal narrowing in the intracranial ICA of SS mice is generating these 
higher velocities. Formation of stenosis are known to occur in sickle cell disease, and often 
associated with high velocities associated with stroke risk [4, 28, 50]. However abnormally 
high velocities can exist in the absence of large stenotic lesions [6]. Gradual narrowing of 
the cerebral arteries rather than a single large stenosis may explain this phenomenon.  
Interestingly, in the Townes model elevated velocities and luminal narrowing was 
more prominent in the ACA rather in the MCA. This may be the results of evolutionary 
differences in the cerebrovascular network between the two species. In mice a majority of 
blood flowing from the ICA diverges into the ACA, providing nutrient to regions in the 
brain near the olfactory bulb. This is important as rodents rely heavily on their olfactory 
senses [134]. In humans, more blood is diverted to the MCA, supplying blood to cognitive 
regions in the brain. 
Calculated velocities were mostly elevated on the right side of the brain. Side to 
side differences in hemodynamic parameters are usually negligible [95, 173, 174], 
therefore, the cause for these differences are not fully known. It has been previously 
reported that the hippocampus, thalamus, and visual cortex on the left side of the brain in 
C57BL/6J mice, one of the background strains for the Townes mice, are enlarged [163]. 
These regions are supplied by several arteries that branch from the ICA and may have 
higher oxygen demands than their counterparts on the right side. Maintaining cerebral 
blood flow to this region could potentially be magnified in the sickle mouse model leading 
side-to-side differences. 
 There are several limitations to this study. First, several tributaries along the ICA 
were removed to reduce computational cost. Addition of these arteries would create 
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additionally flow splits, which ultimately lowers the estimated velocities in the ACA and 
MCA. Future work will focus on using a more complete system which encompasses a more 
accurate representation of the cerebral arterial network. This, however, does not change the 
result that hemodynamic differences between the two genotypes were a result of SCA 
effecting the vascular morphology. Additionally, blood was modeled as a Newtonian 
substance, although this seems appropriate as shear rates in the cerebral arteries remained 
high, this does not consider the Fåhræus-Lindqvist effect. Apparent blood viscosity is a 
function of vessel size and decreases at when diameter is between 10 – 300 microns [175]. 
The cerebral arteries used in this system fall within this range; therefore, the viscosity used 
maybe lower than in the physiological system.  
In conclusion, this study characterizes the velocity in the cerebral arteries of SS and 
AS mice at different ages. While velocities in the CCA and extracranial ICA do not 
significantly differ between AS and SS mice. Narrowing in the cerebral arteries of mice 
afflicted by SCA can significantly increase the blood velocity, one of the primary indicators 
of stroke risk in humans with SCA. Determining the pathological mechanisms for this 
luminal narrowing may help in developing therapeutics for preventing strokes. 
Additionally, such mechanistic studies and treatments can be evaluated using the 
framework of the computational model used in this study.  
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CHAPTER 6  FUTURE CONSIDERATIONS  
6.1 Major Findings 
 The work presented in this thesis focused on developing a more complete 
understanding of the hemodynamic abnormalities associated with stroke risk in children 
with sickle cell anemia. Several paradoxes exist which complicate the overall 
understanding of fluid flow in SCA. To begin, knowledge of flow in tubes suggest that if 
flow rate is kept constant a localized increase in velocity is associated with a decrease in 
cross-sectional area. This principle is somewhat observed in SCA, as histological and 
radiological findings have shown the occurrence of stenotic lesions in individuals with a 
previous history of stroke. However, hemodynamic abnormalities indicative of stroke risk 
can occur before lesions become evident with magnetic resonance angiogram [6]. In 
addition, sickle red blood cells have increased rigidity, density, and viscosity which can 
ultimately impact the rheological properties of whole blood and in theory should slow 
rather increase the blood velocity. Through the utilization of computational fluid dynamics 
this work has elucidated the impact of sickle cell on the cerebrovascular anatomy and its 
effect on hemodynamics. This provides clues for determining the mechanisms associated 
with stroke in SCA. In addition, the framework of the computational models developed in 
this thesis can be used to investigate mechanisms and treatments related to stroke in SCA.  
 The work from the 2D computational model suggests that non-sickle blood has 
similar rheological properties to those so sickle blood in the large arteries. This is primarily 
due to a decrease in the overall hematocrit of whole blood in SCA (~25%), as red blood 
cells have a reduced life expectancy from premature lysing. In fact, extremely low 
hematocrits <20% can cause whole blood viscosity in patients with SCA to drop 
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significantly lower than non-sickle blood, and lead to extremely high velocities [107]. In 
addition, since shear rates in the large arteries exceeded 10 Hz, the computational model 
demonstrated that the sickle blood functions similarly to a non-Newtonian substance. 
Using this assumption can therefore significantly reduce the overall computation cost, 
when performing simulations in the large arteries of people with SCA.  
 Elucidating the influence of stenoses is important to determining the relationship 
between geometry and the hemodynamics. This work showed that even the addition of a 
large stenosis encompassing 75% of the luminal diameter was not enough to produce 
velocities indicative of stroke risk in a 2D model. This indicates that though large stenotic 
lesions are observed through radiological investigations, they are not the root cause for 
elevated velocities in people with SCA. This was confirmed in the 3D computational model 
where simulations were performed from geometries reconstructed from patients with and 
without SCA. This study demonstrated that even when the system was perturbed such that 
the inlet velocity was the same for all subjects, velocities remained elevated in the 
geometries of those with sickle cell. This suggest that SCA is altering the cerebrovascular 
geometry and generating abnormal hemodynamic profiles. Though the number of samples 
for this study was small, two characteristics were observed from the geometries with SCA. 
First though the MCA and ACA lacked any significant stenoses, small bumps were 
observed along the surface of the vascular, and these features appeared correlated to a 
narrowing in the cerebral arteries. The mechanism for these features is not fully 
understood; however, analysis of WSS revealed that the geometries from individuals with 
SCA, had larges areas affected by low and oscillatory shear stress that fell within ±5 
dynes/cm2. This work was published in Experimental Biology and Medicine [176]. 
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 The identification of large areas affected by low WSS in the cerebrovascular of 
patients with SCA, supports the hypothesis that SCA is altering the cerebrovascular 
anatomy. Low and oscillatory wall shear stress can cause endothelial cell dysfunction and 
initiate the beginning stages of vascular remodeling. The gradual narrowing observed in 
the human subjects could explain how velocities can be elevated in individuals with SCA, 
despite the lack of large morphological abnormalities. 
 In an effort to expand our findings from the 3D human simulations, a computational 
model was developed for investigating hemodynamics in the murine cerebrovascular 
system. Mouse models are extremely powerful tools, that can be used for studying 
pathophysiological mechanisms and testing potential therapeutic treatments. 
Unfortunately, few medical devices can measure cerebral artery velocities in a mouse with 
high accuracy.  This creates a need for new methodologies, and CFD can be used to solve 
this problem. This study is among the first to perform 3D CFD simulations in the murine 
cerebrovascular with previous models using 1D approaches [168]. Though found to be 
highly accurate those models assume an average across an entire arterial segment and lack 
the ability to investigate specific geometric features. This model was validated through 
high frequency ultrasound. Diameters calculated in the ICA and eICA of reconstructed 
arteries did not significantly differ from in vivo diameters measured in ultrasound. 
Additionally, simulated velocity waveforms in the eICA was able to recapitulate measured 
ultrasound velocities. 
 Characterization of the vasculature in SS mice revealed that at 12 and 24-weeks the 
left proximal ICA was significantly enlarge in comparison to AS littermate controls. 
However, this morphological difference was lost at distal end, such that no differences 
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were observed in the MCA and ACA. To better characterize this trend luminal area was 
normalized to the proximal end of the artery for each animal. When analyzed in this manner 
the percent change in area was significantly lower in SS at certain sections of the artery. 
These morphological differences suggest two pathologies. First, the larger luminal areas 
measured in SS mice may be an indication of vasodilation in order to generate higher 
cerebral blood flows. Reduced oxygen availability in SCA is compensated by elevated 
cerebral blood flow (CBF) to increase the rate of oxygen delivery [156, 157]. This is 
supported by a reduced cerebral vasculature reserve in humans and mice with sickle cell 
disease [37, 138, 158]. When subjected to hypoxic conditions the blood vessels in SS 
subjects are unable to further dilate leading to a reduced increase in CBF, as compared to 
non-sickle controls. The enlarged lumens measured in the CCA and ICA of our SS mice 
could be attributed to this mechanism. Direct measurements of the luminal area in the 
cerebral arteries have also shown the ICA to be enlarged in humans with sickle cell disease 
[154]. 
Reduction in normalized area in the ICA and ACA of SS mice can be associated 
with luminal narrowing as was observed in human subjects. Subject-specific simulations 
of SS mouse geometries showed that narrowing in the ACA of 12-week SS mice equated 
to an increase in the TAMMV. Though no significant differences were found in the subject-
specific simulations a strong trend of elevated TAMMV was observed. TAMMV had a 
larger variance in the SS group, and these differences may be attributed to different sub-
populations in sickle cell anemia. Applying equivalent inlet velocity conditions; however, 
did significantly elevate the TAMMV in SS, showing that morphological changes in SCA 
can produce elevated velocities. 
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6.2 Examination of biochemical expression from patient specific cerebral 
blood flow 
 An aspect not covered by this thesis is the biomechanical influence of SCA. Current 
shear bioreactors allow for millisecond temporal accuracy, which enables analysis of 
unique patient specific hemodynamics on endothelial cells [177]. Individuals without SCA 
can be compared to those with SCA in order to demine if differences in in hemodynamic 
profiles from different set of patients effects biochemical response. Additionally, different 
stages of stroke risk can be examined by dividing individuals into categories: no history of 
stroke, risk for stroke, and those with a previous history of stroke. Using the computational 
model, magnetic resonance angiograms can be taken from these various subpopulations 
and used to derive wall shear stress profiles at specific locations in the artery. Sites near 
stenoses or vaso-occlusions would be of interest as these are known to stimulate endothelial 
cell dysfunction. Once shear profiles are actuated on to endothelial cells, biomarkers can 
be assayed to determine the impact of various hemodynamic profiles. Correlation of certain 
proteins or kinases to different levels of stroke risk could assist in developing predictive 
model. Currently, TCD is the only widely accepted method of determining stroke risk. 
Identification of certain biomarkers could help clinicians more accurately assess risk and 
provide an avenue for newer treatment options. 
6.3 in vivo investigations of cerebrovascular diseases 
 The findings in this thesis suggests vascular remodeling may be involved in 
producing elevated velocities in SCA. Using the techniques utilized in the computational 
mouse model it is possible to investigate biochemical mechanisms that effect vascular 
remodeling in SCA. Several pathways have been implicated in vascular remodeling and 
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intimal hyperplasia. For example, upregulation of cathepsin K can initiate early stages of 
atherosclerosis [85].  Cathepsin K expression is tightly regulated through both biochemical 
and biomechanical interactions. Increased TNF-α in SCA has been shown to stimulate the 
cathepsin K expression in endothelial cells through JNK and c-Jun kinase pathways [178]. 
Additionally, through NF-κB, shear stress can either suppress or elevate cathepsin K 
expression [179]. Therefore, biomechanical pathway plays an important role in the matrix 
remodeling process.  
 Inhibitors can be used to evaluate the role of cathepsin K on both the vascular 
anatomy and hemodynamics in SCA. SP6000125 is a JNK inhibitor that has been shown 
to block upregulation of cathepsin K through the TNF-α pathway [178], and prevent elastin 
degradation in the carotid arteries of mice. Using the same procedures described in thesis, 
mice given a JNK inhibitor can be evaluated and compared to non-treated counterparts to 
demonstrate efficacy in preventing vascular remodeling. Analysis of morphometric values 
from treated mice can be used to determine if drug treatment prevents the luminal 
narrowing which was observed in this thesis. Simulations on reconstructed mouse models 
will also determine changes in the hemodynamic profiles. Additionally, future 
improvements with imaging modalities such as magnetic resonance angiogram [180] could 
also allow for longitudinal studies. Removing current limitation of endpoint analysis used 
in this system. 
 The computational models developed in this thesis can also be applied to other 
biological systems. Besides the cerebrovascular, sickle cell anemia also impacts various 
other organs. Among these co-morbidities there is an increase likelihood of avascular 
necrosis in the femoral head [181, 182]. This results in bone death leads and loss of 
 122 
mechanical properties, requiring some individuals to have hip replacements during early 
adulthood. Studies have suggested intravascular sickling and the increased viscosity in the 
capillaries are related to  avascular necrosis [183]; however, few studies have examined 
the large arteries in the femur [184]. Additionally, the mouse model developed in this study 
can adopted to investigate other cerebrovascular diseases outside SCA. This is beneficial 
in mice with hundreds pre-existing genetically modified. Some pathologies which can 
benefit from investigating cerebrovascular hemodynamics include Alzheimer’s [185, 186], 






A.1. Script for preforming computational fluid dynamic simulations in LifeV 
#------------------------------------------------- 





    [fluid/problem] 
        preloadT         = 0.0250 #Period of perload waveform 
        startT           = 0. # Time when actual simulations 
starts 
        period           = 0.1445 #Cardiac period for velocity 
waveform used in simulation 
                 
      interpolateBoundaryData = true 
   cosinePreload    = true 
        # Boundary Labels  
        inflowList          = '1' 
        wallList          = '10' 
        RCRList           = '2,3' 
         
 
#Input Boundary Condition 
        [./inflow0] 
            rescale      = 1.0  
            correction   = 1.0 
            smoothRatio  = 0.8 
            profileShape = parabolic 
          dataKind     = velocity 
            input_file   = ../AS/Velocity/12W/050_LICA_M.dat 
        [../] 
 
#Outlet Boundary Conidtions 
        [./outflow0] 
            R1              = 2.8202e6    
            R2              = 8.7776e6  
            C               = 2.3894e-9  
            RT              = 1.1598e7  
        [../] 
 
         [./outflow1] 
           R1      = 2.4575e6  
    R2      = 4.9904e6 
    C                = 2.0128e-9 
    RT      = 7.4479e6   




    [fluid/physics] 
        density          = 1.057        # density    g/cm^3 
        viscosity        = 0.04879      # viscosity g/(cm*s) 
(poise)  
    
    [fluid/space_discretization] 
        mesh_dir         = ../SS/Mesh/12W/ 
        mesh_type        = .vol 
        mesh_file        = 095_LICA_NoPoCA.vol  
        mesh_faces       = all                      # update all 
faces elements 
        mesh_edges       = all                      # update all 
edges elements 
        velocity_fespace = P1Bubble 
        pressure_fespace = P1 
        mass_lumping     = true           # mass lumping 
accelerate convergence, reduce accuracy 
        stiff_strain     = true                 # if true we 
discretize \int (grad(u) + grad(u)^T)*(grad(v) + grad(v)^T) 
        matrix_pattern   = true             #add \int div(w)u*v 
stabilization 
        offlinePartitioning = false 
         
        [./stabilization]  
            betaSD       = 0.5 #0     # scalar parameter of SD 
stabilization 
            divBetaUV    = false    # add \int div(w)u*v 
stabilization 
            stabilizeBackflows = 0. 
        [../] 
         
    [fluid/time_discretization] 
        initialtime      = -0.125  
        endtime          = 0.4350  
        timestep         = 0.0005  
        verbose          = 0 
        BDF_order        = 1  
        order_yosida     = 1  
        nonlinearity_treatment = 0 
 
[miscellaneous] 
    verbose        = 1 
    showdata       = false 
     
[exporter] 
    type           = Ensight 
    post_dir       = ../SS/Results/12W/095_LICA_MS/ 
    multimesh      = false 
    save           = 5 
    exportMode     = 2        # only for VTK export 
    floatPrecision = 1    # only for VTK export 
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    time_id_width  = 6 
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%% Section 1: Extracting Key Variables from Excel Files 
%------------------------------------------------------
------- 




timestep = 0.0025; 
listOfCSVs = dir('*.csv'); 
NumberOfFiles = numel(listOfCSVs); %Total Number of CSV 
Files i.e. number of timesteps 
Nameholder = {listOfCSVs(:).name}; 
Nameholder2 = Nameholder{1,1}; 
token = strtok(Nameholder2,'.'); 
  
%Name of all the filenames organized in time 
ListOfTimes = strings(1,NumberOfFiles);  
for count0 = 0:NumberOfFiles 
%     ListOfTimes(1,count0+1) = 
strcat(token,'.',num2str(count0+1),'.csv'); 




%fnm = rot90(struct2cell(listOfCSVs)); %This needs to 









RAW_slice = cell(1,NumberOfFiles); %Empty Cell to Hold 
all Data from Slice 
for count0 = 1:NumberOfFiles 
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%Extracts x, y, and z corrdinates of points 
%------------------------------------------------------
------- 
Coord3 = zeros(3,NumberOfPoints);%Empty matrix to Hold 
coordinates of all points in the Slice 
for count0 = 1:NumberOfPoints 
    for count1 = 1:3 
        Coord3(count1,count0) = 
RAW_slice{1,1}(count0,4+count1); 
    end 
end 
  
x1 = Coord3(1,:);  
y1 = Coord3(2,:); 








%[Long,Wide] = size(RAW_slice{1,1}); 
Vel = cell(1,NumberOfPoints); 
  
for count1 = 1:NumberOfPoints 
    for count2 = 1:NumberOfFiles 
        for count3 = 1:3 
            Vel{1,count1}(count2,count3) = 
RAW_slice{1,count2}(count1,count3); %Extracting x, y, 
and z values for Velocity 
        end 
        Vel{1,count1}(count2,4) = 
sqrt(Vel{1,count1}(count2,1)^2 + 
Vel{1,count1}(count2,2)^2 + Vel{1,count1}(count2,3)^2); 
%Calculates Magnitude of Velocity 
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    end 
end 
  
%Creates Matrix for both Velocity Magnitude and Time 
Time = zeros(NumberOfFiles,1); 
Mag_Vel = zeros(NumberOfFiles,NumberOfPoints); 
  
for count1 = 1:NumberOfFiles-1 
   Time(count1+1,1) = Time(count1,1)+timestep;%Extracts 
Time   
end 
  
for count1 = 1:NumberOfFiles 
    for count2 = 1:NumberOfPoints 
        Mag_Vel(count1,count2) = 
Vel{1,count2}(count1,4); %Calculates Maximum Velocity   
    end 
end 
  
%Calculate Time of Systole 
collect_mag_vel1 = 0; 
for count1 = 1:NumberOfPoints 
    for count2 = 1:NumberOfFiles 
        collect_mag_vel2 =  Mag_Vel(count2,count1); 
        if collect_mag_vel2 > collect_mag_vel1 
            collect_mag_vel1 = collect_mag_vel2; 
            Time_Max_Vel = count2; 
        else 
            %collect_mag_vel1 = collect_mag_vel1; 
        end 





%Creates cell for Pressure  
%------------------------------------------------------
------- 
Press = cell(1,NumberOfFiles); 
  
for count1 = 1:NumberOfPoints 
    for count2 = 1:NumberOfFiles 
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        Press{1,count2}(count1,1) = 
RAW_slice{1,count2}(count1,4); %Extracting x, y, and z 
values for Velocity 




%% Section 2: Rotates Slice from 3D to 2D Coordiante 
System and Calulates the Perimeter 
%------------------------------------------------------
------- 




bsxfun(@minus,rot90(Coord3),mean(rot90(Coord3))); % Set 
Mean of scatter points to Origin 
[c,xyz] = pca(Coord3_O); % xyz2 will be what you want. 
Coord2 = rot90(xyz,-1); 
  
x2 = Coord2(1,:); 
y2 = Coord2(2,:); 
x2rot = rot90(Coord2(1,:)); 
y2rot = rot90(Coord2(2,:)); 
  
%Check 
xyz_hat = xyz*c'; % xyz_hat = Coord3_O 
  
% Round_xyz_hat = round(xyz_hat, 5); 
% Round_Coord3_O = round(Coord3_O,5); 
%  
% if Round_xyz_hat == Round_Coord3_O 
%     fprintf('Rotation is Good!\n\n'); 
% else 
%     fprintf('Rotation is Bad\n\n'); 
% end 
  






DT = delaunayTriangulation(x2rot,y2rot); 
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k = convexHull(DT); 







Coord2_2 = zeros(NumberOfPoints,2); 
Coord2_2(:,1) = x2rot; 
Coord2_2(:,2) = y2rot; 
  
center_2D = [mean(x2rot); mean(y2rot)]; %Calculates 
Center Using All points 
  
Mag_Coord_2D = zeros(NumberOfPoints,1); %Emty holding 
variable to hold distance of each point from center 1 
  
for count1 = 1:NumberOfPoints 
    Mag_Coord_2D(count1,1) = sqrt( ((center_2D(1,1)) - 




mean1 = mean(Mag_Coord_2D); 
  
[Area_2,Alpha] = alphavol(Coord2_2,mean1/2,1); 
  
Alpha_Cell = struct2cell(Alpha); 
Alpha_Tri = Alpha_Cell{1,1}; 
Alpha_Area = Alpha_Cell{2,1}; 
Alpha_RCC = Alpha_Cell{3,1}; 
Alpha_BD = Alpha_Cell{4,1}; 
  
DT_BD = delaunayTriangulation(x2rot,y2rot,Alpha_BD); 
IO = isInterior(DT_BD); 
IO2 = double(IO); 
  
Connect = DT_BD.ConnectivityList(IO,:); 
Points = DT_BD.Points; 
%  
% %k3 = k(IO, :); 
% %DT3_bd = DT3(IO, :); 
%Area3 = polyarea(DT.Points(k3,1),DT.Points(k3,2)); 
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Time_Setup = toc; 
  




%Interpolated Points in a Grid 
%------------------------------------------------------
------- 
mesh_size = 100; 
x_grid = min(x2rot):(max(x2rot)-
min(x2rot))/mesh_size:max(x2rot); %Proxy points in x 
y_grid = min(y2rot):(max(y2rot)-
min(y2rot))/mesh_size:max(y2rot); %Proxy points in y 
[xq,yq] = meshgrid(x_grid,y_grid); % Grid of proxy 
points 
IN = inpolygon(xq, yq, 
DT_BD.Points(k,1),DT_BD.Points(k,2)); 
IN2 = double(IN); 
  
%Interpolation of Velocity Profile during Systole 
F = scatteredInterpolant(x2rot, y2rot, 
rot90(Mag_Vel(Time_Max_Vel,:)),'linear'); %Creates 
function relating x and y to velocity at arbitary Time 
point 
vq = F(xq,yq); %Calculates Velocity Values for proxy 
points at arbitary Time point 
  
%Interpolation across all time points 
Mag_Vel_interp = cell(1,NumberOfFiles); 
  
for count1 = 1:NumberOfFiles 
f = scatteredInterpolant(x2rot, y2rot, 
rot90(Mag_Vel(count1,:)), 'linear'); 
Mag_Vel_interp{1,count1} = (f(xq,yq)); 





% Create Single Matrix to holding variables for only 




Long2 = length(x_grid); 
Long3 = sum(sum(IN2)); 
interp_coord = zeros(Long3,2); 
interp_v = zeros(Long3,NumberOfFiles); 
  
One_count = 1; 
  
for count1 = 1:Long2 
    for count2 = 1:Long2 
        if IN2(count1, count2) == 1 
            interp_coord(One_count,1) = xq(count1, 
count2); 
            interp_coord(One_count,2) = yq(count1, 
count2); 
            One_count = One_count + 1; 
        else One_count = One_count; 
        end 






k2 = convexHull(DT2); 
  
for count1 = 1:NumberOfFiles 
    One_count = 1; 
    for count2 = 1:Long2 
        for count3 = 1:Long2 
            if IN2(count2, count3) == 1 
                interp_v(One_count,count1) = 
Mag_Vel_interp{1,count1}(count2, count3); 
                One_count = One_count + 1; 
            else One_count = One_count; 
            end 
        end 
    end 
end 
  
Time_Interp = toc; 
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%Integrating Velocity Over Surface  
%------------------------------------------------------
------- 
int1 = zeros(NumberOfFiles,1); 
int2 = zeros(NumberOfFiles,1); 
int3 = zeros(NumberOfFiles,1); 
  



















Velocity(:,1) = Time; 
Velocity(:,2) = int3; 
  
Time_integrating = toc; 
%% Mean Press 
%------------------------------------------------------
------- 
%Calculating Mean Pressure in Slice 
%------------------------------------------------------
------- 
Avg_Press = zeros(1,NumberOfFiles); 
  
for count0 = 1:NumberOfFiles 
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    Avg_Press(1,count0) = mean(Press{1,count0}); 
end 
Press_at_Sys = Avg_Press(1,Time_Max_Vel); 
  









% scatter3(x1,y1,z1,'filled'); %Scatter Plot of Points 
in Slice 
% title('Scatter Plot of Points in 3D'); 
% xlabel('X Coordinates (cm)'); 
% ylabel('Y Coordinates (cm)'); 
% zlabel('z Coordinates (cm)'); 
% legend('Points','Location','Best'); 




% %Plots Scatter Plot of Slice Points Rotated 





% hold on 
% triplot(DT_BD(IO, :),DT_BD.Points(:,1), 
DT_BD.Points(:,2),'k'); 
% hold on 




% title('Scatter Plot of Points Rotated to a 2D 
Coordinate System'); 
% xlabel('X Coordinates (cm)'); 
% ylabel('Y Coordinates (cm)'); 












% hold on 
% plot(DT2.Points(k2,1),DT2.Points(k2,2),'r-'); 
% title('Scatter Plot of Interpolated Points in 2D 
System'); 
% xlabel('X Coordinates (cm)'); 











% title('Average Velocity of Slice'); 
% xlabel('Time (s)'); 
% ylabel('Average Velocity (cm/s)'); 
% legend('Integration Using Given Points','Integration 
Using Interpolated Points','Integration Using Given 








% scatter3(x2rot, y2rot, 
rot90(Mag_Vel(floor(Time_Max_Vel),:)),'r','filled'); 
%Plots known points at arbirary time 
% hold on; 
% mesh(xq,yq,vq); %Plots interpolated Grid 
% hold on 
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% plot(xq(IN),yq(IN),'k+') 
% hold on; 
% plot(xq(~IN),yq(~IN),'m+') 
% hold on; 
% plot(DT.Points(k,1),DT.Points(k,2),'r-
','LineWidth',4); %Plots Perimeter of slice 
% title('3D Representation of Velocity'); 
% xlabel('X Coordinates (cm)'); 
% ylabel('Y Coordinates (cm)'); 
% zlabel('Velocity (cm/s)'); 
% legend('Given Points','Interpolated Values','Area of 
Integration','Area Outside of 
Integration','Perimeter','Location','Best') 
%  
% hcb = colorbar; 
% colorTitleHandle = get(hcb,'Title'); 
% titleString = 'Velocity (cm/s)'; 
% set(colorTitleHandle ,'String',titleString); 
% rotate3d on; 
%  
% Time_Plots = toc; 
  








%fprintf('Total Time %4.3f s\n', Time_Setup + 
Time_Interp + Time_integrating + Time_Plots); 
Round_xyz_hat = round(xyz_hat, 5); 
Round_Coord3_O = round(Coord3_O,5); 
  
if Round_xyz_hat == Round_Coord3_O 
    fprintf('Rotation is Good!\n\n'); 
else 
    fprintf('Rotation is Bad\n\n'); 
end 
  
fprintf('Area of Slice (Normal Triangulation): %4.7f 
cm^2\n', Area); 
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fprintf('Area of Slice (Alpha  Triangulation): %4.7f 
cm^2\n', Area_2); 
fprintf('Maximum Velocity: %4.2f cm/s\n', 
max(max(Mag_Vel))); 
fprintf('Maximum Flow Rate: %4.7f cm^3/s\n\n', 
max(max(Mag_Vel))*Area_2); 
  
fprintf('Velocity Measurments Using Integration 
Method:\n'); 
fprintf('Maximum Value for Integration of Given Points: 
%4.2f cm/s\n', max(int1));  
fprintf('Maximum Value for Integration of Interpolated 
Points: %4.2f cm/s \n', max(int2));  
fprintf('Maximum Value for Integration of Given Points 
with Alpha Triangulation: %4.2f cm/s \n', max(int3)); 
fprintf('Flow Rate: %4.7f cm^3/s\n',max(int3)*Area_2); 
fprintf('Mean Pressure at Systole: %4.2f 
dynes/cm^2/s\n\n',Press_at_Sys); 
  






A.3. Matlab code for calculating time-average mean waveforms  
function [avg, x, peakSV, avgVel, endVel, T, aT, dT, 
pI, rI] = processVelocity(matrix, lengths, name) 
%processVelocity Processes velocity data to get the avg 
waveform and its 
%key characteristics 
[diff, meanX, meanY] = checkXValues(matrix, lengths, 
name); %Checks for and removes duplicate X values 
  
% Separates the file name into its component parts 
[~, rem] = strtok(name, '\'); 
for ndx = 1:7 
    [~, rem] = strtok(rem, '\'); 
end 
[typeWeek, rem] = strtok(rem, '\'); 
[type, week] = strtok(typeWeek, '_'); 
week(1) = []; 
[num, rem] = strtok(rem, '\'); 
[art, ~] = strtok(rem, '\'); 
myTitle = sprintf('%s : %sW : %s : %s', type, week, 
num, art); %Creates title for the graph 
myTitle_Profile = sprintf('%s_%sW_%s_%s', type, week, 
num, art); %Creates title for the graph 
if (strcmp(myTitle, 'WT : 6W : 119 : LICA')) 
    stopper = false; 
end 
  
p1 = meanX(1); 
p2 = meanX(end); 
%Removes NaN values from the end of the mean data 
while (isnan(p2)) 
    meanX(end) = []; 
    meanY(end) = []; 
    p2 = meanX(end); 
end 
delta = 0.0005; %Sets the delta desired between x 
values 
%Adjusts delta if the actual difference between the x 
values is smaller 
%than the preset delta 
while (diff < delta) 
    delta = delta - 0.0001; 
end 
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newX = p1:delta:p2; %Generates a new set of x values 
% Interpolates using spline y values to correspond with 
the new x values. 
% This is done to have the x and y values be 
consistently spaced 
try 
[meanY] = interp1(meanX, meanY, newX, 'spline'); 
catch 
    stopper = false; 
end 
% Determines the thresholds for the wave data 
maxY = max(meanY); 
maxP = 0.20; 
maxT = maxY - (maxP * maxY); %Max threshold 
minT = median(meanY); %Min threshold 
xVals = newX(meanY >= maxT); %Grabs xVals above the max 
threshold 
% Plots the wave form data with the thresholds 
  
% figure 
% hold on; 
% xlabel('Time (s)', 'FontSize', 24); 
% ylabel('Velocity (mm/s)', 'FontSize', 24); 
% plot(newX, meanY); 
% plot([newX(1),newX(end)], [maxT, maxT]); 
% plot([newX(1),newX(end)], [minT, minT]); 
  
% Uses Fourier Transform to filter data 
fourier = fft(meanY); 
fourierM = abs(fourier); 
four_filter = zeros(1, length(fourierM)); 
[order,originalpos] = sort(fourierM, 'descend' ); 
thresh = order(1,15); 
for r = 1:length(fourierM) 
    if fourierM(1,r) < thresh 
        four_filter(1,r) = 0; 
    else  
        four_filter(1,r) = fourier(1,r); 
    end 
end 
four_filterMag = abs(four_filter); 
inverse_fourier = ifft(four_filter); 
  
% plot(newX, inverse_fourier) 
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maxY2 = max(inverse_fourier); 
maxP2 = 0.25; 
maxT2 = maxY2 - (maxP2 * maxY2); %Max threshold 
minT2 = median(inverse_fourier); %Min threshold 
xVals2 = newX(inverse_fourier >= maxT2); 
  
if (any(strcmp(myTitle, {'WT : 4W : 120 : LICA', 'WT : 
4W : 120 : RICA', 'WT : 4W : 122 : LICA', 'WT : 4W : 
125 : LICA'}))) 
    maxT2 = maxT2 + 15; 
end 
if (any(strcmp(myTitle, {'WT : 6W : 116 : LICA', 'WT : 
6W : 118 : LICA'}))) 
    maxT2 = maxT2 + 22; 
end 
if (any(strcmp(myTitle, {'WT : 4W : 123 : LICA', 'WT : 
6W : 119 : LICA'}))) 
    maxT2 = maxT2 + 25; 
end 
  
% plot([newX(1),newX(end)], [maxT2, maxT2]); 
% plot([newX(1),newX(end)], [minT2, minT2]); 
% set(gca,'FontSize',18) 
  
xVals3 = newX(meanY >= maxT2); %Catches more peaks 
  
% [mat] = splitPeaks(xVals, (delta + .0001)); 
%Seperates the the x values into groups of peaks 
% [mat3] = splitPeaks(xVals2, (delta + .0001));  
[mat4] = splitPeaks(xVals3, (delta + .0001)); 
%Seperates the the x values into groups of peaks 
[peaks] = getPeaks(mat4, meanY, newX, myTitle); %Gets 
the highest peak and x value from each set of x values 
in mat4 
[mat2] = getWaves(peaks, minT, meanY, newX, myTitle); 
%Gets the waveform associated with each peak and 
removes bad waveforms 
[r, ~] = size(mat2); 
% Plots each wave form and a before shift avg and a 





% hold on; 
  
yVectors = []; 
for ndx = 1:r 
    xVec = mat2{ndx, 1}(2,:); 
    yVec = mat2{ndx, 1}(1,:); 
    colorVal = 0.8; %Causes line to be light gray 
%     plot(xVec, yVec, 'color', [colorVal, colorVal, 
colorVal]); 
    [~, c] = size(yVectors); 
    if (~isempty(yVectors)) 
        [~, c2] = size(yVec); 
        if (c2 >= c) 
            yVec = yVec(1:c); 
        else 
            yVectors = yVectors(:, 1:c2); 
        end 
    end 
%     Stores the waveforms and conforms to shortest 
wave form 
    yVectors = [yVectors; yVec]; 
end 
avg = mean(yVectors); %Gets the average wave form 
[~, col] = size(avg); 
x = 0:delta:(col - 1) * delta; 
% Plots the avg wave form 
% graph1 = plot(x, avg, '-k'); 
% set(graph1,'LineWidth',2); 
% xlabel('Time (s)', 'FontSize', 24); 
% ylabel('Velocity (mm/s)', 'FontSize', 24); 
% Plots shifted data 
% figure 
% subplot(1,1,1); 
% hold on; 
% graph1 = plot(x, avg, '--b'); 
% xlabel('Time (s)', 'FontSize', 24); 
% ylabel('Velocity (mm/s)', 'FontSize', 24); 
% set(graph1,'LineWidth',2); 
  
[mat2, yVecAVG, remIndex] = phaseShift(mat2, myTitle); 
%Corrects out of phase waveforms 
[r, ~] = size(mat2); 
for ndx = 1:r 
    xVec = mat2{ndx, 1}(2,:); 
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    yVec = mat2{ndx, 1}(1,:); 
    colorVal = 0.8; %Causes line to be light gray 
%     plot(xVec, yVec, 'color', [colorVal, colorVal, 
colorVal]); 
end 
avg = nanmean(yVecAVG); %Gets the average wave form 
discluding NaNs 
avg(1:remIndex) = []; 
avg = snipper(avg, myTitle); 
avg = smoother(avg); 
[~, col] = size(avg); 
[~, Avg_PSV_Index] = max(avg); 
[~, maxYVal_Index] = max(mat2{1, 1}(1,:)); 
maxXVal = mat2{1, 1}(2,maxYVal_Index); 
x = 0:delta:(col - 1) * delta; 
maxAvgX = x(Avg_PSV_Index); 
diffX = maxXVal - maxAvgX; 
x = x + diffX; 
% Plots the avg wave form 
  
% graph1 = plot(x, avg, '-k'); 
x = x - diffX; 
% set(graph1,'LineWidth',2); 
% set(gca,'FontSize',18) 
% title(myTitle, 'FontSize', 32); 
%  
% title(myTitle, 'FontSize', 18); 
fprintf([myTitle, '\n']) %Prints the title into command 
window to show which file the function has processed 
% Plots the avg and the max and min lines of the 
waveform data 
% box on; 
% hold off; 
% figure; 
% maxAvg = max(yVectors); 
% minAvg = min(yVectors); 
% hold on; 
% X=[x, fliplr(x)];                %create continuous x 
value array for plotting 
% Y=[maxAvg,fliplr(minAvg)];              %create y 
values for out and then back 
% fill(X,Y,[0.5, 0.8, 0.95]);  
% graph2 = plot(x, avg, '-k'); 
% set(graph2,'LineWidth',2); 
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% xlabel('Time (s)', 'FontSize', 16); 
% ylabel('Velocity (mm/s)', 'FontSize', 16); 
% myTitle = sprintf('%s : %sW : %s : %s', type, week, 
num, art); 
% title(myTitle, 'FontSize', 18); 
% box on; 
% hold off; 
%Extracts the key characteristics from the avg wave 
form 
[peakSV, x2] = max(avg); 
avgVel = mean(avg); 
endVel = avg(end); 
T = x(end); 
% x2 = x(avg == peakSV); 
x1 = x(1); 
y2 = peakSV; 
y1 = avg(1); 
aT = x2 - x1; 
dT = (y2 - y1)/aT; 
pI = (peakSV - endVel)/avgVel; 
rI = (peakSV - endVel)/peakSV; 
  
% Export the velocity profile of mouse to excel sheet 
avg = avg./10; 
profile = num2cell([x',avg']); 
header = {'Time', 'Velocity'}; 
myLength = cell(1, 2); 
myLength{1, 2} = length(avg) + 1; 
header = [header; myLength]; 
profile = [header; profile]; 
[rNum, ~] = size(profile); 
period = cell(rNum, 3); 
period{1, 2} = 'Period'; 
period(3:7, 2) = {'delta t'; 'T'; '3T'; '4T'; '5T'}; 
period(3:7, 3) = {round((x(2) - x(1)), 4); T; 3*T; 4*T; 
5*T}; 





function [delta, x, y] = checkXValues(mat, lengths, 
name) 
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% checkXValues Checks for duplicate x values and 
removes them if possible 
x = mat(:, 1); 
y = mat(:, 2); 
%Separates the file name into its component parts 
[~, rem] = strtok(name, '\'); 
for ndx = 1:7 
    [~, rem] = strtok(rem, '\'); 
end 
[typeWeek, rem] = strtok(rem, '\'); 
[num, rem] = strtok(rem, '\'); 
[art, ~] = strtok(rem, '\'); 
name = sprintf('%s : %s : %s', typeWeek, num, art); 
%Name of the data being processed 
  
num1 = x(1); 
num2 = x(2); 
delta = num2 - num1; %Determines the delta between two 
points in the x values 
[r, ~] = size(x); 
removeVector = []; 
%Iterates through the x values looking for duplicates 
for ndx = 1:r - 3 
    x1 = x(ndx); 
    x2 = x(ndx + 1); 
    x3 = x(ndx + 2); 
    x4 = x(ndx + 3); 
    y1 = y(ndx); 
    y2 = y(ndx + 1); 
    y3 = y(ndx + 2); 
    y4 = y(ndx + 3); 
    %Throws exception if there are three duplicate x 
values 
    if (x1 == x2 == x3) 
        ind = ndx; 
        stopper = true; 
        counter = 1; 
        %Determines where the duplicates are to output 
in the exception 
        while stopper 
            if ind < lengths(1) 
                stopper = false; 
            else 
                ind = ind - lengths(1); 
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                lengths(1) = []; 
                counter = counter + 1; 
            end 
        end 
        msgID2 = 'Data:DuplicateXValue'; 
        msg2 = sprintf('There is at least one duplicate 
X value in %s at index %d in file %d', name, ind, 
counter); 
        baseException = MException(msgID2,msg2); 
        throw(baseException);  
    end 
%     Handles the case where two duplicate x values are 
found 
    if (x2 == x3) 
        m = (y4 - y1)/(x4 - x1); 
        newY = m*x2 + (y1-x1*m); 
        diff2 = abs(newY - y2); 
        diff3 = abs(newY - y3); 
        if (diff2 >= diff3) 
            removeVector = [removeVector, ndx + 1]; 
        else 
            removeVector = [removeVector, ndx + 2]; 
        end 
    end 
%     Adjusts delta to be the small possible 
    diff = num2 - num1; 
    if (diff < delta) 
        delta = diff; 
    end 
end 
% Removes the duplicate x values and corresponding y 
values 
x(removeVector) = []; 
y(removeVector) = []; 
end 
  
function [mat] = splitPeaks(xVals, delta) 
% getWaves splits a vector of x values into the 
individual waveforms and 
% stored in the output matrix 
xVals(end + 1) = 0; 
[~, c] = size(xVals); 
ind1 = 1; 
mat = []; 
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for ndx = 1:c - 1 
   num1 = xVals(ndx); 
   num2 = xVals(ndx + 1); 
   if ((num2 - num1) > delta || num2 == 0) 
       ind2 = ndx; 
       vec = xVals(ind1:ind2); 
       ind1 = ndx + 1; 
       vec = {vec}; 
       mat = [mat; vec]; 




function [peaks] = getPeaks(mat, yVec, xVec, myTitle) 
% getPeaks Takes in the matrices of the x values and 
returns the peaks of 
% the waveforms and their respective x values; 
[r, ~] = size(mat); 
peaks = zeros(2,r); 
% Iterates through mat and picks the highest point in 
each 
for ndx = 1:r 
    vec = mat{ndx, 1}; 
    [~, c] = size(vec); 
    xMax = vec(1); 
    yMax = yVec(xMax == xVec); 
    for ind = 2:c 
        x = vec(ind); 
        y = yVec(x == xVec); 
        if (y > yMax) 
            yMax = y; 
            xMax = x; 
        end 
    end 
    %Stores the highest peak in terms of x and y in 
peaks 
    peaks(1, ndx) = yMax; 
    peaks(2, ndx) = xMax; 
end 
    [~, c] = size(peaks); 
    if (any(strcmp(myTitle, {'SS : 6W : 085 : LICA'}))) 
        remVec = 1:c; 
        log = peaks(1, :) < 100; 
        remInd = remVec(log); 
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        peaks(:, remInd) = []; %removes "peaks" that 
are not actually peaks 
    end  
    [~, c] = size(peaks); 
    counter = 1; 
%     Removes peaks that are too close together to 
indicate the peak of a 
%     new wave form 
    while counter < c 
        x1 = peaks(2, counter); 
        x2 = peaks(2, counter + 1); 
        log1 = (x2 - x1) < 0.1; 
        y1 = peaks(1, counter); 
        y2 = peaks(1, counter + 1); 
        log2 = y1 > y2; 
        log3 = y2 > y1; 
        if (log1 && log2) 
            peaks(:, counter + 1) = []; 
            c = c - 1; 
        elseif (log1 && log3) 
            peaks(:, counter) = []; 
            c = c - 1; 
        else 
            counter = counter + 1; 
        end 
    end 
end 
  
function [mat] = getWaves(peaks, minT, yVec, xVec, 
myTitle) 
% getWaves Splits velocity data into valid single 
waveforms and stores them 
% in a matrix. Invalid waveforms will be discarded 
[~, c] = size(peaks); 
startVec = zeros(1, c); 
remVec = []; 
% Iterates through each peak to extract its wave form 
for ndx = 1:c 
    ind = find(peaks(2, ndx) == xVec); 
    stopper = true; 
%     Heads backward from the peak to determine the 
wave's start 
    while stopper 
        ind = ind - 1; 
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        if (ind <=1) 
            remVec = [remVec, ndx]; 
            stopper = false; 
        else 
            y1 = yVec(ind); 
            y2 = yVec(ind - 1); 
            diff = y2 - y1; 
            if (y2 > minT && diff > 0) %Will remove 
this peak b/c it indicates an artifact in the wave 
%                 remVec = [remVec, ndx]; 
            elseif (y2 < minT && diff > 0) %Stores this 
start index 
                startVec(1,ndx) = ind; 
                stopper = false; 
            elseif (ind <= 2) %Will remove this wave 
because it cannot have a start 
                remVec = [remVec, ndx]; 
                stopper = false; 
            elseif (ndx > 1) %Prevents the start of 
current wave from going beyond previous wave 
                if (ind <= startVec(ndx - 1)) 
                    startVec(1,ndx) = ind; 
                    stopper = false; 
                end 
            end 
        end 
    end 
end 
remVec = unique(remVec); 
endVec = zeros(1,c); 
diffVec = zeros(1,c-1); 
%Generates end of wave index vector and difference 
vector 
for ndx = 1:c - 1 
    endVec(ndx) = startVec(ndx + 1); 
    diffVec(ndx) = peaks(2, ndx + 1) - peaks(2, ndx);  
end 
[~, c2] = size(xVec); 
endVec(end) = c2; 
  
peaks = [peaks; startVec; endVec]; 
diff2 = endVec - startVec; 
avg2 = mean(diff2); 
dev2 = std(diff2); 
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lB2 = avg2 - (1.5 * dev2); 
uB2 = avg2 + (2.5 * dev2); 
lB2 = floor(lB2); 
uB2 = floor(uB2); 
if (any(strcmp(myTitle, {'WT : 6W : 118 : LICA'}))) 
    uB2 = uB2 - 5; 
end 
if (any(strcmp(myTitle, {'SS : 12W : 036 : LICA', 'SS : 
12W : 036 : RICA', 'SS : 24W : 025 : RCCA', 'SS : 4W : 
101 : RICA', 'WT : 24W : 111 : LCCA', 'WT : 6W : 114 : 
LICA'}))) 
    uB2 = uB2 - 20; 
end 
if (any(strcmp(myTitle, {'SS : 4W : 095 : LICA'}))) 
    uB2 = uB2 - 27; 
end 
if (any(strcmp(myTitle, {'AS : 6W : 135 : RICA', 'SS : 
12W : 045 : LICA', 'SS : 24W : 068 : RCCA', 'WT : 4W : 
125 : LCCA', 'WT : 6W : 116 : LICA', 'WT : 6W : 119 : 
LICA'}))) 
    uB2 = uB2 - 50; 
end 
if (any(strcmp(myTitle, {'WT : 24W : 110 : RCCA', 'WT : 
24W : 113 : RICA'}))) 
    uB2 = uB2 - 100; 
end 
if (any(strcmp(myTitle, {'SS : 24W : 068 : LCCA', 'SS : 
12W : 037 : LICA', 'AS : 6W : 138 : LICA', 'WT : 24W : 
111 : RCCA'}))) 
    uB2 = uB2 - 175; 
end 
if (any(strcmp(myTitle, {'SS : 6W : 069 : RCCA', 'SS : 
24W : 027 : LCCA', 'SS : 6W : 128 : LICA', 'WT : 4W : 
123 : LICA', 'WT : 6W : 116 : LCCA'}))) 
    lB2 = lB2 - 2; 
end 
if (any(strcmp(myTitle, {'AS : 6W : 135 : RICA', 'SS : 
12W : 036 : LICA', 'SS : 24W : 003 : RCCA', 'SS : 12W : 
045 : RCCA', 'SS : 4W : 101 : RICA', 'WT : 24W : 109 : 
RICA', 'WT : 4W : 123 : LCCA', 'WT : 6W : 114 : LICA', 
'WT : 6W : 116 : LICA'}))) 
    lB2 = lB2 + 20; 
end 
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if (any(strcmp(myTitle, {'AS : 12W : 091 : LICA', 'AS : 
6W : 086 : RICA', 'AS : 6W : 073 : RICA', 'AS : 6W : 
097 : LICA', 'WT : 24W : 111 : RICA', 'WT : 4W : 125 : 
RICA', 'WT : 6W : 119 : LICA'}))) 
    lB2 = lB2 + 50; 
end 
if (any(strcmp(myTitle, {'SS : 12W : 037 : LICA', 'SS : 
12W : 045 : LICA', 'AS : 4W : 099 : RICA', 'WT : 24W : 
112 : LICA', 'WT : 24W : 113 : RICA', 'WT : 6W : 114 : 
RICA'}))) 
    lB2 = lB2 + 100; 
end 
for ndx = 1:c 
    val = diff2(ndx); 
%     Removes waves that are too short or drastically 
too longwhen compared to the lengths of the 
%     other vectors 
    if (val < lB2 || val > uB2) 
        remVec = [remVec, ndx]; 
    end 
end 
remVec = unique(remVec); 
peaks(:, remVec) = []; %Removes the bad wave forms 
[~, c3] = size(peaks); 
% Stores the wave forms in a cell array 
mat = cell(c3, 1); 
for ndx = 1:c3 
    v1 = peaks(3, ndx); 
    v2 = peaks(4, ndx) - 1; 
    range = v1:v2; 
    xWave = xVec(range); 
    try 
    xWave = xWave - xWave(1); 
    catch 
        stop = false; 
    end 
    yWave = yVec(peaks(3, ndx) : peaks(4, ndx) - 1); 
    newCell = {[yWave; xWave]}; 
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